{"title": "Post-vaccination anti-HBs testing among healthcare workers: More economical than post-exposure management for Hepatitis B", "author": "Souza; Camila Lucas de; Salgado; Tha\u00eds de Arvelos; Sardeiro; Tatiana Luciano; Galdino Junior; H\u00e9lio; Itria; Alexander; Tipple; Anaclara Ferreira Veiga", "url": "https://www.scielo.br/j/rlae/a/m3VTbQJzTKhv7ysBNvVJSTk/", "hostname": "scielo.br", "description": "Objective: to compare the direct cost, from the perspective of the Unified Health System, of...", "sitename": "Revista Latino-Americana de Enfermagem", "date": "2020-06-19", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Abstracts\nObjective:\nto compare the direct cost, from the perspective of the Unified Health System, of assessing the post-vaccination serological status with post-exposure management for hepatitis B among health care workers exposed to biological material.\nMethod:\ncross-sectional study and cost-related, based on accident data recorded in the System of Information on Disease Notification between 2006 and 2016, where three post-exposure and one pre-exposure management scenarios were evaluated: A) accidents among vaccinated workers with positive and negative serological status tests for hepatitis B, exposed to known and unknown source-person; B) handling unvaccinated workers exposed to a known and unknown source-person; C) managing vaccinated workers and unknown serological status for hepatitis B and D) cost of the pre-exposure post-vaccination test. Accidents were assessed and the direct cost was calculated using the decision tree model.\nResults:\nscenarios where workers did not have protective titles after vaccination or were unaware of the serological status and were exposed to a positive or unknown source-person for hepatitis B.\nConclusion:\nthe direct cost of hepatitis B prophylaxis, including confirmation of serological status after vaccination would be more economical for the health system.\nDescriptors:\nOccupational Exposure; Health Personnel; Hepatitis B Vaccines; Hepatitis B Antibodies; Costs and Cost Analysis; Health Care Costs\nObjetivo:\ncomparar o custo direto, sob a perspectiva do Sistema \u00danico de Sa\u00fade, da avalia\u00e7\u00e3o do status sorol\u00f3gico p\u00f3s-vacina\u00e7\u00e3o com o manejo p\u00f3s-exposi\u00e7\u00e3o para hepatite B entre trabalhadores da \u00e1rea da sa\u00fade expostos ao material biol\u00f3gico.\nM\u00e9todo:\nestudo transversal e de custo, realizado a partir dos dados de acidentes registrados no Sistema de Informa\u00e7\u00e3o de Agravos de Notifica\u00e7\u00e3o entre 2006 e 2016, em que foram avaliados tr\u00eas cen\u00e1rios de manejo p\u00f3s-exposi\u00e7\u00e3o e um de pr\u00e9-exposi\u00e7\u00e3o: A) acidentes entre trabalhadores vacinados com status sorol\u00f3gico positivo e negativo para hepatite B, expostos \u00e0 pessoa-fonte conhecida e desconhecida; B) manejo dos trabalhadores n\u00e3o vacinados expostos \u00e0 pessoa-fonte conhecida e desconhecida; C) manejo dos trabalhadores vacinados e status sorol\u00f3gico desconhecido para hepatite B e D) custo do teste p\u00f3s vacina\u00e7\u00e3o pr\u00e9-exposi\u00e7\u00e3o. Os acidentes foram avaliados e o custo direto foi calculado utilizando o modelo \u00e1rvore de decis\u00e3o.\nResultados:\napresentaram maior custo os cen\u00e1rios em que os trabalhadores n\u00e3o possu\u00edam t\u00edtulos protetores ap\u00f3s a vacina\u00e7\u00e3o ou desconheciam o status sorol\u00f3gico e foram expostos \u00e0 pessoa-fonte positivo ou desconhecida para hepatite B.\nConclus\u00e3o:\no custo direto da profilaxia para hepatite B, incluindo a confirma\u00e7\u00e3o do status sorol\u00f3gico ap\u00f3s vacina\u00e7\u00e3o seria mais econ\u00f4mico para o sistema de sa\u00fade.\nDescritores:\nExposi\u00e7\u00e3o Ocupacional; Pessoal de Sa\u00fade; Vacinas contra Hepatite B; Anticorpos Anti-Hepatite B; Custos e An\u00e1lise de Custo; Custos de Cuidados de Sa\u00fade\nObjetivo:\ncomparar el costo directo, desde la perspectiva del Sistema \u00danico de Salud, de la evaluaci\u00f3n del status serol\u00f3gico post-vacunaci\u00f3n con el manejo post-exposici\u00f3n para la hepatitis B entre los trabajadores de la salud expuestos a material biol\u00f3gico.\nM\u00e9todo:\nestudio transversal y de costos, basado en datos de accidentes registrados en el Sistema de Informaci\u00f3n de Enfermedades Notificables entre 2006 y 2016, en el que se evaluaron tres escenarios de gesti\u00f3n posteriores a la exposici\u00f3n y uno previo a la exposici\u00f3n: A) accidentes entre trabajadores vacunados con status serol\u00f3gico positivo y negativo para hepatitis B, expuestos a una fuente de origen conocida y desconocida; B) manejo de trabajadores no vacunados expuestos a una fuente conocida y desconocida; C) manejo de trabajadores vacunados y estado serol\u00f3gico desconocido para hepatitis B y D) costo de la prueba de pre-exposici\u00f3n post-vacunaci\u00f3n. Se evaluaron los accidentes y se calcul\u00f3 el costo directo utilizando el modelo de \u00e1rbol de decisi\u00f3n.\nResultados:\nlos escenarios en los que los trabajadores no ten\u00edan t\u00edtulos de protecci\u00f3n despu\u00e9s de la vacunaci\u00f3n o desconoc\u00edan el status serol\u00f3gico y estaban expuestos a una persona fuente positiva o desconocida para la hepatitis B reflejaron un costo m\u00e1s alto.\nConclusi\u00f3n:\nel costo directo de la profilaxis para la hepatitis B, incluida la confirmaci\u00f3n del status serol\u00f3gico despu\u00e9s de la vacunaci\u00f3n ser\u00eda m\u00e1s econ\u00f3mico para el sistema de salud.\nDescriptores:\nExposici\u00f3n Ocupacional; Personal de Salud; Vacunas contra Hepatitis B; Anticuerpos contra la Hepatitis B; Costos y An\u00e1lisis de Costo; Costos de la Atenci\u00f3n en Salud\nIntroduction\nIn the world, approximately 257 million individuals live with chronic hepatitis B virus (HBV) infection(11 World Health Organization. Global hepatitis report 2017. [Internet]. Geneva: World Health Organization; 2017. [cited April 13, 2018]. Available from: https://apps.who.int/iris/bitstream/handle/10665/255016/9789241565455eng.pdf;jsessionid=0DA6245F73DE62CA74AFDA377EDEAAC9?sequence=1\n[https://apps.who.int/iris/bitstream/hand...\n](https://apps.who.int/iris/bitstream/handle/10665/255016/9789241565455eng.pdf;jsessionid=0DA6245F73DE62CA74AFDA377EDEAAC9?sequence=1)). It is known that the cost of treating this disease is high(22 Wiens A, Lenzi L, Venson R, Pedroso ML, Correr CJ, Pontarolo R. Economic evaluation of treatments for chronic hepatitis B. Braz J Infect Dis. 2013;17(4): 418-26. doi: https://doi.org/10.1016/j.bjid.2012.12.005\n[https://doi.org/10.1016/j.bjid.2012.12.0...\n](https://doi.org/10.1016/j.bjid.2012.12.005)-33 Zhang S, Ma Q, Liang S, Xiao H, Zhuang G, Zou Y, et al. Annual economic burden of hepatitis B virus-related diseases among hospitalized patients in twelve cities in China. J Viral Hepat. 2016;23(3):202-10. doi: https://doi.org/10.1111/jvh.12482\n[https://doi.org/10.1111/jvh.12482...\n](https://doi.org/10.1111/jvh.12482)).\nIn Brazil, 233,027 confirmed hepatitis B cases were reported in the period from 1999 to 2018, with detection rates of 6.7/100,000 inhabitants in 2018, in which 0.3% of the transmission occurred through the occupational route(44 Minist\u00e9rio da Sa\u00fade (BR). Boletim epidemiol\u00f3gico de hepatites virais. [Internet]. 2019. [Acesso 20 out 2019]. Dispon\u00edvel em: http://www.aids.gov.br/pt-br/pub/2019/boletim-epidemiologico-de-hepatites-virais-2019\n[http://www.aids.gov.br/pt-br/pub/2019/bo...\n](http://www.aids.gov.br/pt-br/pub/2019/boletim-epidemiologico-de-hepatites-virais-2019)).\nInfection by occupational exposure can occur during accidents with biological material among Health Care Workers (HCW), according to studies that show rates of 17.3% to 58.4% in Brazil(55 Carvalho DC, Rocha JC, Gimenes MCA, Santos EC, Valim MD. Work incidents with biological material in the nursing team of a hospital in Mid-Western Brazil. Esc Anna Nery. [Internet]. 2018 [cited Apr 20, 2018];22(1): 1-8. Available from: http://www.scielo.br/pdf/ean/v22n1/1414-8145-ean-2177-9465-EAN-2017-0140.pdf\n[http://www.scielo.br/pdf/ean/v22n1/1414-...\n](http://www.scielo.br/pdf/ean/v22n1/1414-8145-ean-2177-9465-EAN-2017-0140.pdf)-66 Negrinho NBS, Malaguti-Toffano SE, Reis RK, Pereira FMV, Gir E. Factors associated with occupational exposure to biological material among nursing professionals. Rev Bras Enferm. [Internet]. 2017 [cited Jun 20, 2018];70(1): 126-31. Available from: http://www.scielo.br/pdf/reben/v70n1/en_0034-7167-reben-70-01-0133.pdf\n[http://www.scielo.br/pdf/reben/v70n1/en_...\n](http://www.scielo.br/pdf/reben/v70n1/en_0034-7167-reben-70-01-0133.pdf)) and 36,7 % to 78,0% in other countries(77 Nouetchognou JS, Ateudjieu J, Jemea B, Mbanya D. Accidental exposures to blood and body fluids among health care workers in a Referral Hospital of Cameroon. BMC Res Notes. [Internet]. 2016 [cited Jul 10, 2018];9(94):1-6. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753641/pdf/13104_2016_Article_1923.pdf\n[https://www.ncbi.nlm.nih.gov/pmc/article...\n](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753641/pdf/13104_2016_Article_1923.pdf)\n8 Garus-Pakowska A, G\u00f3rajski M, Szatko F. Awareness of the risk of exposure to infectious material and the behaviors of Polish paramedics with respect to the hazards from blood-borne pathogens - a nationwide study. Int J Environ Res Public Health. [Internet]. 2017 [cited Ago 10, 2018];14(843):1-9. doi: 10.3390/ijerph14080843\n[https://doi.org/10.3390/ijerph14080843...\n](https://doi.org/10.3390/ijerph14080843)-99 Matsubara C, Sakisaka K, Sychareun V, Phensavanh A, Ali M. Prevalence and risk factors of needle stick and sharp injury among tertiary hospital workers, Vientiane, Lao PDR. Occup Health. [Internet]. 2017 [cited Nov 20, 2018];59(6):581-5. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721280/pdf/1348-9585-59-581.pdf\n[https://www.ncbi.nlm.nih.gov/pmc/article...\n](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721280/pdf/1348-9585-59-581.pdf)).\nIn view of the risk of exposure to HBV, the main preventive measure is the vaccination(1010 Centers for Disease Control and Prevention. CDC Guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management. MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports. [Internet]. 2013 [cited Nov 20, 2018];62(RR):1-22. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm\n[https://www.cdc.gov/mmwr/preview/mmwrhtm...\n](https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm)). In Brazil, the Unified Health System (SUS - abbreviation in Portuguese) bears the costs of the HBV vaccine within the National Immunization Program, making it available free of charge since 1998(1111 Minist\u00e9rio da Sa\u00fade (BR). Programa Nacional de Imuniza\u00e7\u00f5es (PNI): 40 anos. [Internet]. 2013 [Acesso 20 mar 2018]. Dispon\u00edvel em: http://bvsms.saude.gov.br/bvs/publicacoes/programa_nacional_imunizacoes_pni40.pdf\n[http://bvsms.saude.gov.br/bvs/publicacoe...\n](http://bvsms.saude.gov.br/bvs/publicacoes/programa_nacional_imunizacoes_pni40.pdf)).\nThe vaccine is safe and effective, ensuring 92% protection for immunocompetent adults(1212 Averhoff F, Mahoney F, Coleman P, Schatz G, Hurwitz E, Margolis H. Immunogenicity of hepatitis B Vaccines. Implications for persons at occupational risk of hepatitis B virus infection. Am J Prev Med. [Internet]. 1998 [cited Nov 20, 2018];15(1):1-8. doi: https://doi.org/10.1016/S0749-3797(98)00003-8\n[https://doi.org/10.1016/S0749-3797(98)00...\n](https://doi.org/10.1016/S0749-3797(98)00003-8)). Despite the high protection, it is recommended after vaccination to perform antibodies against surface antigen (anti-HBs) to confirm immunity to the virus(1010 Centers for Disease Control and Prevention. CDC Guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management. MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports. [Internet]. 2013 [cited Nov 20, 2018];62(RR):1-22. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm\n[https://www.cdc.gov/mmwr/preview/mmwrhtm...\n](https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm)).\nUnlike the HBV vaccine, the anti-HBs test is not routinely available in the public health system after vaccination in Brazil.\nIn handling the accident with biological material, considering the recommendations of the Centers for Disease Control and Prevention (CDC)(1010 Centers for Disease Control and Prevention. CDC Guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management. MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports. [Internet]. 2013 [cited Nov 20, 2018];62(RR):1-22. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm\n[https://www.cdc.gov/mmwr/preview/mmwrhtm...\n](https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm)) and the Ministry of Health in Brazil(1313 Minist\u00e9rio da Sa\u00fade (BR). Protocolo cl\u00ednico e diretrizes terap\u00eauticas para profilaxia p\u00f3s-exposi\u00e7\u00e3o (pep) de risco \u00e0 infec\u00e7\u00e3o pelo HIV, IST, e hepatites virais. [Internet]. 2018 [Acesso 20 nov 2018]. Dispon\u00edvel em: http://www.aids.gov.br/pt-br/pub/2015/protocolo-clinico-e-diretrizes-terapeuticas-para-profilaxia-pos-exposicao-pep-de-risco\n[http://www.aids.gov.br/pt-br/pub/2015/pr...\n](http://www.aids.gov.br/pt-br/pub/2015/protocolo-clinico-e-diretrizes-terapeuticas-para-profilaxia-pos-exposicao-pep-de-risco)), evaluation of vaccination history and serological status is required for the hepatitis B of HCW and HBV serological status testing for hepatitis B by the surface antigen (HBsAg) from the known source-person at the time of occupational exposure.\nAfter this assessment at the time of the accident, four approaches can be adopted considering the Guidance for Evaluating Health-Care Personnel for Hepatitis B Virus Protection and for Administering Postexposure Management protocol - CDC(1010 Centers for Disease Control and Prevention. CDC Guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management. MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports. [Internet]. 2013 [cited Nov 20, 2018];62(RR):1-22. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm\n[https://www.cdc.gov/mmwr/preview/mmwrhtm...\n](https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm)). Depending on the serological status of the source-person and the victim, the conducts are: No conduct, realizing the vaccine, realizing the vaccine and administering a dose of Hyperimmune Immunoglobulin for Hepatitis B (IGHAHB) and administering two doses of IGHAHB. In the last three aforementioned conducts, the injured worker must perform the anti-HBs test after the vaccine one to two months after the last dose and after four to six months of this immunoglobulin(1010 Centers for Disease Control and Prevention. CDC Guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management. MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports. [Internet]. 2013 [cited Nov 20, 2018];62(RR):1-22. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm\n[https://www.cdc.gov/mmwr/preview/mmwrhtm...\n](https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm)).\nThe management of accidents with biological material among HCW is expensive in several countries, mainly in percutaneous exposures(1414 O\u2019Malley EM, Scott RD 2nd, Gayle J, Dekutoski J, Foltzer M, Lundstrom TS, et al. Costs of management of occupational exposures to blood and body fluids. Infect Control Hosp Epidemiol. 2007;28(7):774-82. doi: https://doi.org/10.1086/518729\n[https://doi.org/10.1086/518729...\n](https://doi.org/10.1086/518729)\n15 Oh HS, Yoon Chang SW, Choi JS, Park ES, Jin HY. Costs of postexposure management of occupational sharps injuries in health care workers in the Republic of Korea. Am J Infect Control. 2013;41(1):61-5. doi: https://doi.org/10.1016/j.ajic.2012.01.030\n[https://doi.org/10.1016/j.ajic.2012.01.0...\n](https://doi.org/10.1016/j.ajic.2012.01.030)\n16 Lee JM, Botteman MF, Xanthakos N, Nicklasson L. Needlestick injuries in the United States. Epidemiologic, economic, and quality of life issues. AAOHN J. [Internet]. 2005 [cited Nov 20, 2018];53(3):117-33. Available from: https://www.ncbi.nlm.nih.gov/pubmed/15789967\n[https://www.ncbi.nlm.nih.gov/pubmed/1578...\n](https://www.ncbi.nlm.nih.gov/pubmed/15789967)\n17 Leigh JP, Gillen M, Franks P, Sutherland S, Nguyen HH, Steenland K, et al. Costs of needlestick injuries and subsequent hepatitis and HIV infection. Curr Med Res Opin. 2007;23(9):2093-105. doi: https://doi.org/10.1185/030079907X219517\n[https://doi.org/10.1185/030079907X219517...\n](https://doi.org/10.1185/030079907X219517)-1818 Mannocci A, De Carli G, Di Bari V, Saulle R, Unim B, Nicolotti N, et al. How much do needlestick injuries cost? A systematic review of the economic evaluations of needlestick and sharps injuries among healthcare personnel. Infect Control Hosp Epidemiol. 2016;37(6):635-46. doi: https://doi.org/10.1017/ice.2016.48\n[https://doi.org/10.1017/ice.2016.48...\n](https://doi.org/10.1017/ice.2016.48)). Although the performance of the anti-HBs test among these workers is a recommendation of the Ministry of Health and Labor through the Regulatory Norm (NR) 32/2005(1919 Minist\u00e9rio da Sa\u00fade (BR). Recomenda\u00e7\u00f5es para terapia antirretroviral em adultos infectados pelo HIV- 2008. Suplemento III - Tratamento e preven\u00e7\u00e3o. [Internet]. 2010. [Acesso 10 jan 2017]. Dispon\u00edvel em: http://www.aids.gov.br/sites/default/files/pub/2016/59204/suplemento_consenso_adulto_01_24_01_2011_web_pdf_13627.pdf\n[http://www.aids.gov.br/sites/default/fil...\n](http://www.aids.gov.br/sites/default/files/pub/2016/59204/suplemento_consenso_adulto_01_24_01_2011_web_pdf_13627.pdf)-2020 Minist\u00e9rio do Trabalho e Emprego (BR). Portaria n.\u00ba 485, de 11 de novembro de 2005. NR 32- Seguran\u00e7a e Sa\u00fade no Trabalho em Servi\u00e7os de Sa\u00fade. [Internet]. 2005 [Acesso 20 jan 2018]. Dispon\u00edvel em: https://www20.anvisa.gov.br/segurancadopaciente/index.php/legislacao/item/portaria-n-485-de-11-de-novembro-de-2005\n[https://www20.anvisa.gov.br/segurancadop...\n](https://www20.anvisa.gov.br/segurancadopaciente/index.php/legislacao/item/portaria-n-485-de-11-de-novembro-de-2005)) and the CDC(1010 Centers for Disease Control and Prevention. CDC Guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management. MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports. [Internet]. 2013 [cited Nov 20, 2018];62(RR):1-22. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm\n[https://www.cdc.gov/mmwr/preview/mmwrhtm...\n](https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm)), it is known that a considerable part of the vaccinated HCW ignore the serological status for the HBV(55 Carvalho DC, Rocha JC, Gimenes MCA, Santos EC, Valim MD. Work incidents with biological material in the nursing team of a hospital in Mid-Western Brazil. Esc Anna Nery. [Internet]. 2018 [cited Apr 20, 2018];22(1): 1-8. Available from: http://www.scielo.br/pdf/ean/v22n1/1414-8145-ean-2177-9465-EAN-2017-0140.pdf\n[http://www.scielo.br/pdf/ean/v22n1/1414-...\n](http://www.scielo.br/pdf/ean/v22n1/1414-8145-ean-2177-9465-EAN-2017-0140.pdf),2121 Arantes MC, Haddad MCFL, Marcon SS, Rossaneis MA, Pissinati PSC, Oliveira SA. Occupational accidents with biological material among healthcare workers. Cogitare Enferm [Internet]. 2017 Jan-Mar [cited Jan 20, 2018];22(1):1-8. Available from: https://revistas.ufpr.br/cogitare/article/view/46508/pdf_en\n[https://revistas.ufpr.br/cogitare/articl...\n](https://revistas.ufpr.br/cogitare/article/view/46508/pdf_en)\n22 Garbin CAS, Wakayama B, Dias IA, Bertocello LM, Garbin AJI. Hepatitis B and occupational exposure in the dental setting. The valuation of the knowledge and professionals attitudes. J Health Sci. [Internet]. 2017 [cited Ago 18, 2018];19(2):209-13. Available from: http://pgsskroton.com.br/seer/index.php/JHealthSci/article/view/5053/3683\n[http://pgsskroton.com.br/seer/index.php/...\n](http://pgsskroton.com.br/seer/index.php/JHealthSci/article/view/5053/3683)-2323 Cavalcante MLR, Viana LS, Vasconcelos JO, Linhares MSC. Perfil dos acidentes de trabalho com exposi\u00e7\u00e3o a material biol\u00f3gico no munic\u00edpio de Sobral-Cear\u00e1, 2007 a 2014. Essentia. [Internet]. 2016 [Acesso 8 set 2018];17(2):1-22. Dispon\u00edvel em: http://www.uvanet.br/essentia/index.php/revistaessentia/article/view/75/84\n[http://www.uvanet.br/essentia/index.php/...\n](http://www.uvanet.br/essentia/index.php/revistaessentia/article/view/75/84)). Ignoring this status at the time of the accident with a positive source-person requires a high-cost intervention with immunoglobulin, which would turn expensive the post-exposure handling related to the HBV(1515 Oh HS, Yoon Chang SW, Choi JS, Park ES, Jin HY. Costs of postexposure management of occupational sharps injuries in health care workers in the Republic of Korea. Am J Infect Control. 2013;41(1):61-5. doi: https://doi.org/10.1016/j.ajic.2012.01.030\n[https://doi.org/10.1016/j.ajic.2012.01.0...\n](https://doi.org/10.1016/j.ajic.2012.01.030)).\nIn the economic studies, the direct cost involves technology costs for health interventions, including drugs and exams(2424 Silva EN, Silva MT, Pereira MG. Identifying, measuring and valuing health costs. Epidemiol Serv Sa\u00fade. [Internet]. 2016 Abr-Jun [cited Feb 20, 2018];25(2): 437-9. Available from: http://scielo.iec.gov.br/pdf/ess/v25n2/2237-9622-ess-25-02-00437.pdf.\n[http://scielo.iec.gov.br/pdf/ess/v25n2/2...\n](http://scielo.iec.gov.br/pdf/ess/v25n2/2237-9622-ess-25-02-00437.pdf)-2525 Minist\u00e9rio da Sa\u00fade (BR). Secretaria de Ci\u00eancia, Tecnologia e Insumos Estrat\u00e9gicos. Departamento de Ci\u00eancia e Tecnologia. Diretrizes metodol\u00f3gicas: diretriz de avalia\u00e7\u00e3o econ\u00f4mica. [Internet]. 2014. [Acesso 20 jan 2018]. Dispon\u00edvel em: http://bvsms.saude.gov.br/bvs/publicacoes/diretrizes_metodologicas_diretriz_avaliacao_economica.pdf\n[http://bvsms.saude.gov.br/bvs/publicacoe...\n](http://bvsms.saude.gov.br/bvs/publicacoes/diretrizes_metodologicas_diretriz_avaliacao_economica.pdf)). The evaluation of costs in the health area is increasingly present in the management of health services; therefore, good quality scientific evidence on costs and health outcomes helps in the decision-making(2626 Silva EN, Silva MT, Pereira MG. Health economic evaluation studies: definition and applicability to health systems and services. Epidemiol Serv Sa\u00fade. [Internet]. 2016 Jan/Mar [cited Fev 20, 2018];25:(1):205-7. Available from: http://scielo.iec.gov.br/pdf/ess/v25n1/v25n1a23.pdf\n[http://scielo.iec.gov.br/pdf/ess/v25n1/v...\n](http://scielo.iec.gov.br/pdf/ess/v25n1/v25n1a23.pdf)).\nSince the post-vaccination anti-HBs test is not routinely offered to the worker free of charge by SUS, it was asked what is the lowest cost related to occupational exposure to HBV?\nIn this sense, the aim of this study was to compare the direct cost, from the perspective of the Unified Health System, of assessing the post-vaccination serological status with post-exposure management for hepatitis B among health care workers exposed to biological material.\nMethod\nCross-sectional, descriptive and partial economic evaluation study, focusing on the direct cost of occupational post-exposure management to biological material. The study\u2019s population was HCW that suffered accident with exposure to biologic material notified in the database of Aggravated Notification Information System (SINAN-NET), in the municipality of Goi\u00e2nia, in the period from 2006 to 2016, which corresponds to the beginning of the notifications from the municipality until the last year in which the data were completed and marked a 10-year period of notifications.\nThe study site is located in the Midwest region of Brazil. According to the Brazilian Institute of Geography and Statistics in 2017, this municipality had 1,466,105 inhabitants(2727 Instituto Brasileiro de Geografia Estat\u00edstica. Estimativas de popula\u00e7\u00e3o. Estimativas da popula\u00e7\u00e3o residente no Brasil e unidades da Federa\u00e7\u00e3o com data de refer\u00eancia em 1\u00ba de julho de 2017. [Internet] 2017. [Acesso 10 jan 2020]. Dispon\u00edvel em: ftp://ftp.ibge.gov.br/Estimativas_de_Populacao/Estimativas_2017\n[ftp://ftp.ibge.gov.br/Estimativas_de_Pop...\n](ftp://ftp.ibge.gov.br/Estimativas_de_Populacao/Estimativas_2017)). There were 3,281 health facilities (public, philanthropic and private networks) and 25,367 HCW working in the health services(2828 Minist\u00e9rio da Sa\u00fade (BR). Cadastro Nacional de Estabelecimentos de Sa\u00fade. CNESnet - Secretaria de Aten\u00e7\u00e3o \u00e0 Sa\u00fade DATASUS. Estabelecimentos cadastrados no Estado Goi\u00e1s. [Internet] 2017. [Acesso 10 jan 2020]. Dispon\u00edvel em: http://cnes.datasus.gov.br/pages/estabelecimentos/consulta.jsp\n[http://cnes.datasus.gov.br/pages/estabel...\n](http://cnes.datasus.gov.br/pages/estabelecimentos/consulta.jsp)).\nTo evaluate the direct cost of performing the anti-HBs test and the management after exposure to the HBV, the analyzed epidemiological variables were: gender, age, education, professional category, biological material involved, object involved, type of exposure, hepatitis B vaccine of HCW, HCW anti-HBs test, identification of the source-person and HBsAg of the source-person.\nFrom such data, four scenarios were evaluated, representing the possibilities of intervention considering the serological status of the source-person and injured HCW (A, B, C, D), considering the recommendations of CDC(1010 Centers for Disease Control and Prevention. CDC Guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management. MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports. [Internet]. 2013 [cited Nov 20, 2018];62(RR):1-22. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm\n[https://www.cdc.gov/mmwr/preview/mmwrhtm...\n](https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm)), adopted as a reference for providing greater protection to the workers. In scenario A and B, the direct costs for HBV-related post-exposure management were quantified among HCW exposed to biological material from real data, considering the previous vaccination and the result of the worker\u2019s anti-HBs test performed at the time of accident (scenario A) or the non-vaccination of the same (scenario B). While, in scenario C, the costs of post-exposure management for HBV by simulation were measured, considering epidemiological studies. In this scenario, the HCW did not know the result of the anti-HBs test at the time of occupational exposure, and for the simulation one considered the immunogenicity rate of 92%(1212 Averhoff F, Mahoney F, Coleman P, Schatz G, Hurwitz E, Margolis H. Immunogenicity of hepatitis B Vaccines. Implications for persons at occupational risk of hepatitis B virus infection. Am J Prev Med. [Internet]. 1998 [cited Nov 20, 2018];15(1):1-8. doi: https://doi.org/10.1016/S0749-3797(98)00003-8\n[https://doi.org/10.1016/S0749-3797(98)00...\n](https://doi.org/10.1016/S0749-3797(98)00003-8)), the known source-person rate of 73%(2121 Arantes MC, Haddad MCFL, Marcon SS, Rossaneis MA, Pissinati PSC, Oliveira SA. Occupational accidents with biological material among healthcare workers. Cogitare Enferm [Internet]. 2017 Jan-Mar [cited Jan 20, 2018];22(1):1-8. Available from: https://revistas.ufpr.br/cogitare/article/view/46508/pdf_en\n[https://revistas.ufpr.br/cogitare/articl...\n](https://revistas.ufpr.br/cogitare/article/view/46508/pdf_en),2929 Goel V, Kumar D, Lingaiah R, Singh S. Occurrence of needlestick and injuries among health-care workers of a tertiary care teaching hospital in North India. J Lab Physicians. [Internet]. 2017 Jan-Mar [cited Jun 2, 2018];9(1):20-5. Available from: http://www.jlponline.org/temp/JLabPhysicians9120-4059725_111637.pdf\n[http://www.jlponline.org/temp/JLabPhysic...\n](http://www.jlponline.org/temp/JLabPhysicians9120-4059725_111637.pdf)\n30 Sistema de Vigil\u00e2ncia de Acidentes de Trabalho com material biol\u00f3gico em servi\u00e7os de sa\u00fade brasileiros (BR). Relat\u00f3rio PSBio. 1\u00aa fase: 2002 a 2004, 2\u00aa fase: 2005 a 2015. [Internet]. Rio de Janeiro: PSBio; 2015. [Acesso 2 jun 2018];1-21. Dispon\u00edvel em: https://www.riscobiologico.org/psbio/psbio_201505.pdf\n[https://www.riscobiologico.org/psbio/psb...\n](https://www.riscobiologico.org/psbio/psbio_201505.pdf)-3131 Santos SS, Costa NA, Mascarenhas MDM. Caracteriza\u00e7\u00e3o das exposi\u00e7\u00f5es ocupacionais a material biol\u00f3gico entre trabalhadores de hospitais no Munic\u00edpio de Teresina, Estado do Piau\u00ed, Brasil, 2007 a 2011. Epidemiol Serv Sa\u00fade. [Internet]. 2013 Jan-Mar [Acesso 12 dez 2018];22(1):165-70. Dispon\u00edvel em: http://scielo.iec.gov.br/pdf/ess/v22n1/v22n1a17.pdf\n[http://scielo.iec.gov.br/pdf/ess/v22n1/v...\n](http://scielo.iec.gov.br/pdf/ess/v22n1/v22n1a17.pdf)) and the prevalence of positive HBsAg source-person of 1.0%(2121 Arantes MC, Haddad MCFL, Marcon SS, Rossaneis MA, Pissinati PSC, Oliveira SA. Occupational accidents with biological material among healthcare workers. Cogitare Enferm [Internet]. 2017 Jan-Mar [cited Jan 20, 2018];22(1):1-8. Available from: https://revistas.ufpr.br/cogitare/article/view/46508/pdf_en\n[https://revistas.ufpr.br/cogitare/articl...\n](https://revistas.ufpr.br/cogitare/article/view/46508/pdf_en),3030 Sistema de Vigil\u00e2ncia de Acidentes de Trabalho com material biol\u00f3gico em servi\u00e7os de sa\u00fade brasileiros (BR). Relat\u00f3rio PSBio. 1\u00aa fase: 2002 a 2004, 2\u00aa fase: 2005 a 2015. [Internet]. Rio de Janeiro: PSBio; 2015. [Acesso 2 jun 2018];1-21. Dispon\u00edvel em: https://www.riscobiologico.org/psbio/psbio_201505.pdf\n[https://www.riscobiologico.org/psbio/psb...\n](https://www.riscobiologico.org/psbio/psbio_201505.pdf)-3131 Santos SS, Costa NA, Mascarenhas MDM. Caracteriza\u00e7\u00e3o das exposi\u00e7\u00f5es ocupacionais a material biol\u00f3gico entre trabalhadores de hospitais no Munic\u00edpio de Teresina, Estado do Piau\u00ed, Brasil, 2007 a 2011. Epidemiol Serv Sa\u00fade. [Internet]. 2013 Jan-Mar [Acesso 12 dez 2018];22(1):165-70. Dispon\u00edvel em: http://scielo.iec.gov.br/pdf/ess/v22n1/v22n1a17.pdf\n[http://scielo.iec.gov.br/pdf/ess/v22n1/v...\n](http://scielo.iec.gov.br/pdf/ess/v22n1/v22n1a17.pdf)).\nIn scenario D, the direct costs of the HBV prevention measure were measured by performing the anti-HBs test 30 days after the last dose of the vaccine, considering that the injured HCW had performed this primary post-vaccination test and before the accident with biological material, considering the same immunogenicity rate as scenario C.\nThis study evaluated the direct cost from SUS perspective, according to the current table of values of the Management System of the Table of Procedures, Medicines and Orthotics, Prostheses and Special Materials (SIGTAP).\nFor the calculations, we first used the Brazilian currency in Reais (R$) that was converted to the U.S. dollar (US$) with a value of 1 US$=R$ 3.26, based on the price of 07/15/2016, available on the site of the Central Bank of Brazil.\nThe values of the technologies (unitary costs) used in this study were US$ 5.69 the anti-HBs test, US$ 5.69 the HbsAg test, US$ 259.75 the IGHAHB of 500 International Units (IU) and US$ 3.07 medical consultation in worker\u2019s health. The costs were calculated considering the number of HCW multiplied by the value of the test or technology (anti-HBs, HBsAg, IGHAHB and medical consultation) in each scenario.\nThe cost of the vaccine was not considered in this study for economic analysis, as it was assumed that it would not bring financial impact, since this cost is predicted by the SUS for all HCW(1111 Minist\u00e9rio da Sa\u00fade (BR). Programa Nacional de Imuniza\u00e7\u00f5es (PNI): 40 anos. [Internet]. 2013 [Acesso 20 mar 2018]. Dispon\u00edvel em: http://bvsms.saude.gov.br/bvs/publicacoes/programa_nacional_imunizacoes_pni40.pdf\n[http://bvsms.saude.gov.br/bvs/publicacoe...\n](http://bvsms.saude.gov.br/bvs/publicacoes/programa_nacional_imunizacoes_pni40.pdf)).\nEpidemiological data were processed and analyzed by Statistical Package for the Social Sciences (SPSS\u00ae), version 20.0 using descriptive statistics. The following criteria were considered for data analysis based on the CDC recommendation(1010 Centers for Disease Control and Prevention. CDC Guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management. MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports. [Internet]. 2013 [cited Nov 20, 2018];62(RR):1-22. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm\n[https://www.cdc.gov/mmwr/preview/mmwrhtm...\n](https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm)):\n-\nVaccinated HCW - those who received the three doses of hepatitis B vaccine reported by the worker;\n-\nNon-vaccinated HCW - those who did not receive the three doses of the vaccine, vaccine situation ignored and without information;\n-\nHCW with protective titers to HBV - those with anti-HBs test >10 IU/ millilitres (ml);\n-\nHCW without protective titers to HBV - those with anti-HBs test;\n-\nUnknown source-person - those with inconclusive HBsAg test, not performed, ignored and without information, whose management, recommended by the CDC(1010 Centers for Disease Control and Prevention. CDC Guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management. MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports. [Internet]. 2013 [cited Nov 20, 2018];62(RR):1-22. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm\n[https://www.cdc.gov/mmwr/preview/mmwrhtm...](https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm)), is the same for those with positive HBsAg;\n-\nVaccinated HCW and with unknown anti-HBs test - those with inconclusive test, not performed, ignored or without information.\n-\nFor the cost analysis of IGHAHB, the prescription of 500 IU was considered as the standard dose, since it is the minimum dosage prescribed for adults(3232 Minist\u00e9rio da Sa\u00fade (BR). Secretaria de Vigil\u00e2ncia em Sa\u00fade. Departamento de Vigil\u00e2ncia das Doen\u00e7as Transmiss\u00edveis. Manual dos Centros de Refer\u00eancia para imunobiol\u00f3gicos especiais. [Internet]. 2014. [Acesso 12 dez 2018]. Dispon\u00edvel em http://portalarquivos.saude.gov.br/images/pdf/2014/dezembro/09/manual-cries-9dez14-web.pdf\n[http://portalarquivos.saude.gov.br/image...](http://portalarquivos.saude.gov.br/images/pdf/2014/dezembro/09/manual-cries-9dez14-web.pdf)).\nThe economic analysis used was the decision tree model; this graphic representation begins from the left with a decision node, which is divided into branches that propose to evaluate comparatively. In each branch, the probabilities of events must be described until the final event. Therefore, a series of probability nodes appear in each branch. At the end of these branches, the outcomes are presented as terminal node, indicating the final impacts of each branch with their respective costs associated with each analyzed event(3333 Petrou S, Gray A. Economic evaluation using decision analytical modelling: design, conduct, analysis, and reporting. BMJ. 2011;342:d1766. doi: https://doi.org/10.1136/bmj.d1766\n[https://doi.org/10.1136/bmj.d1766...\n](https://doi.org/10.1136/bmj.d1766)-3434 So\u00e1rez PC, Soares MO, Novaes HMD. Decision modeling for economic evaluation of health technologies. Ci\u00eanc Sa\u00fade Coletiva. [Internet]. 2014 [cited Jun 2, 2017];19 (10):4209-22. Available from: http://www.scielo.br/pdf/csc/v19n10/1413-8123-csc-19-10-4209.pdf\n[http://www.scielo.br/pdf/csc/v19n10/1413...\n](http://www.scielo.br/pdf/csc/v19n10/1413-8123-csc-19-10-4209.pdf)).\nThe approach used for the analysis was macrocosting or some top-down method, which allows for a cost analysis of secondary data retrospectively(2424 Silva EN, Silva MT, Pereira MG. Identifying, measuring and valuing health costs. Epidemiol Serv Sa\u00fade. [Internet]. 2016 Abr-Jun [cited Feb 20, 2018];25(2): 437-9. Available from: http://scielo.iec.gov.br/pdf/ess/v25n2/2237-9622-ess-25-02-00437.pdf.\n[http://scielo.iec.gov.br/pdf/ess/v25n2/2...\n](http://scielo.iec.gov.br/pdf/ess/v25n2/2237-9622-ess-25-02-00437.pdf)).\nA study approved in the research ethics committee of Clinical Hospital, Federal University of Goi\u00e1s, under protocol no. 41425/2013.\nResults\nThere were recorded 7,265 accidents with biological material among HCW in the city of Goi\u00e2nia from 2006 to 2016, aged from 21 - 30 years old (39.3%), with a predominance of females (80.5%) and with high school education (43.0%). The most exposed team was nursing (55.2%), followed by the physician (10.2%).\nRegarding the profile of accidents with biological material, percutaneous exposures predominated (72.4%) in the presence of blood (74.4%), and the most involved objects were needles with and without lumen (62.1%).\nFor post-exposure management of biological material it is necessary to know the vaccination history against hepatitis B and serological status (anti-HBs test) of the HCW at the time of the accident and the serological status (HBsAg) of the source-person when known. Regarding the vaccination history against hepatitis B, it was recorded in the accident notification form that 6,184 (85.1%) workers had received all three doses of the vaccine, 542 (7.5%) were not vaccinated or did not complete the vaccination schedule and in 539 (7.4%) cases there was no record of this information.\nRegarding serological status to HBV, of the 6,184 vaccinated HCW (\n[Figure 1]()), 2,756 (44.6%) performed the anti-HBs test, of which 1,758 (63.8%) had protective titers at the time of the accident and 998 (36.2%) didn\u2019t have it. Of the 3,428 workers who did not undergo the anti-HBs test ( [Figure 3]()), when considering the 92% immunogenicity rate for hepatitis B vaccine, it is assumed that 3,154 (92%) had protective titles for the virus and 274 (8%) would not possess.\nEconomic analysis of post-exposure management for hepatitis B among health care workers, victims of accidents with biological material, vaccinated against hepatitis B (3 doses) and anti-HBs at the time of the accident, considering the recommendations of the Centers for Disease Control and Prevention. Goi\u00e2nia, GO, Brazil, 2006-2016\n*HCW = Health Care Worker; \u2020anti-HBs = Antibody against hepatitis B virus surface antigen; \u2021US$ = Conversion rate: 1 US$=3,26 in 07/15/2016; \u00a7HBsAg = Surface antigen for hepatitis B; ||IGHAHB = Immunoglobulin hyper-immune for hepatitis B\nEconomic analysis of post-exposure management for hepatitis B among health care workers, victims of accidents with biological material, not vaccinated against hepatitis B (3 doses), exposed to known and unknown source people, exposed to known and unknown source people, considering the recommendations of the Centers for Disease Control and Prevention. Goi\u00e2nia, GO, Brazil, 2006-2016\n*HCW = Health Care Worker; \u2020HBsAg = Surface antigen for hepatitis B ; \u2021anti-HBs = Antibody against hepatitis B virus surface antigen; \u00a7US$ = Conversion rate: 1 US$=3.26 in 07/15/2016; ||IGHAHB = Immunoglobulin hyper-immune for hepatitis B\nEconomic analysis of the simulation of occupational post-exposure management of biological material for hepatitis B among health care workers, victims of accidents with biological material, vaccinated and with unknown anti-HBs test after the accident with biological material, considering the recommendations of the Centers for Disease Control and Prevention. Goi\u00e2nia, GO, Brazil, 2006-2016\n*HCW = Health Care Worker; \u2020anti-HBs = Antibody against hepatitis B virus surface antigen; \u2021US$ = Conversion rate: 1 US$=3,26 in 07/15/2016; \u00a7HBsAg = Surface antigen for hepatitis B; ||IGHAHB = Immunoglobulin hyper-immune for hepatitis B\nRegarding the serological status (HBsAg) of the source-person, a prevalence of positive HBsAg was observed among known source people of 1.8% (95% CI: 1.0 - 3.2). Among vaccinated HCW against hepatitis B and with anti-HBs <10 IU\\/ml, the prevalence of positive HBsAg with known source-person was 0.9% (95% CI: 0.3 - 2.0) and among unvaccinated HCW, the prevalence of positive HBsAg with known source-person was 5.1% (95% CI: 2.3 - 9.8).\nThe costs were presented in the branches of the \u201cdecision tree\u201d model, with the costs of post-exposure management described in scenarios A (\n[Figure 1]()), B ( [Figure 2]()) and C ( [Figure 3]()) and the cost of post-vaccination prevention primary in scenario D ( [Figure 4]()).\nEconomic analysis of the evaluation of serological status after primary vaccination for hepatitis B among health care workers, victims of accidents with biological material, considering the recommendations of the Centers for Disease Control and Prevention. Goi\u00e2nia, GO, Brazil, 2006-2016\n*HCW = Health Care Worker; \u2020anti-HBs = Antibody against hepatitis B virus surface antigen; \u2021US$ = Conversion rate: 1 US$=3,26 in 07/15/2016\nThe cost of prevention measures before the accident with biological material and the management after exposure to HBV among the injured HCW in relation to vaccination history and serological status for the HBV of the worker and the source-person is described in\n[Table 1]().\nEconomic analysis of prevention measures and post-exposure management among health care workers, victims of accidents with biological material in the municipality of Goi\u00e2nia. Goi\u00e2nia, GO, Brazil, 2006-2016\nDiscussion\nThe predominance, in this study, of accidents with biological material among female HCW, agrees with other Brazilian studies(55 Carvalho DC, Rocha JC, Gimenes MCA, Santos EC, Valim MD. Work incidents with biological material in the nursing team of a hospital in Mid-Western Brazil. Esc Anna Nery. [Internet]. 2018 [cited Apr 20, 2018];22(1): 1-8. Available from: http://www.scielo.br/pdf/ean/v22n1/1414-8145-ean-2177-9465-EAN-2017-0140.pdf\n[http://www.scielo.br/pdf/ean/v22n1/1414-...\n](http://www.scielo.br/pdf/ean/v22n1/1414-8145-ean-2177-9465-EAN-2017-0140.pdf)-66 Negrinho NBS, Malaguti-Toffano SE, Reis RK, Pereira FMV, Gir E. Factors associated with occupational exposure to biological material among nursing professionals. Rev Bras Enferm. [Internet]. 2017 [cited Jun 20, 2018];70(1): 126-31. Available from: http://www.scielo.br/pdf/reben/v70n1/en_0034-7167-reben-70-01-0133.pdf\n[http://www.scielo.br/pdf/reben/v70n1/en_...\n](http://www.scielo.br/pdf/reben/v70n1/en_0034-7167-reben-70-01-0133.pdf),2121 Arantes MC, Haddad MCFL, Marcon SS, Rossaneis MA, Pissinati PSC, Oliveira SA. Occupational accidents with biological material among healthcare workers. Cogitare Enferm [Internet]. 2017 Jan-Mar [cited Jan 20, 2018];22(1):1-8. Available from: https://revistas.ufpr.br/cogitare/article/view/46508/pdf_en\n[https://revistas.ufpr.br/cogitare/articl...\n](https://revistas.ufpr.br/cogitare/article/view/46508/pdf_en),3535 Cordeiro TMSC, Carneiro JN Neto, Cardoso MCB, Mattos AIS, Santos KOB, Ara\u00fajo TM. Occupational accidents with exposure to biological material: description of cases in Bahia. J Epidemiol Infect Control. [Internet]. 2016 [cited Dec 12, 2018];6(2):1-7. doi: http://dx.doi.org/10.17058/reci.v6i2.6218\n[http://dx.doi.org/10.17058/reci.v6i2.621...\n](http://dx.doi.org/10.17058/reci.v6i2.6218)-3636 Barros DX, Tipple AFV, Lima LKOL, Souza ACS, Neves ZCP, Salgado TA. Analysis of 10 years of accidents with biological material among the nursing staff. Rev Eletr Enferm. 2016;18:e1157. doi: http://dx.doi.org/10.5216/ree.v18.35493\n[http://dx.doi.org/10.5216/ree.v18.35493...\n](http://dx.doi.org/10.5216/ree.v18.35493)) and of other countries(99 Matsubara C, Sakisaka K, Sychareun V, Phensavanh A, Ali M. Prevalence and risk factors of needle stick and sharp injury among tertiary hospital workers, Vientiane, Lao PDR. Occup Health. [Internet]. 2017 [cited Nov 20, 2018];59(6):581-5. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721280/pdf/1348-9585-59-581.pdf\n[https://www.ncbi.nlm.nih.gov/pmc/article...\n](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721280/pdf/1348-9585-59-581.pdf),3737 Samargandy SA, Bukhari LM, Samargandy SA, Bahlas RS, Aldigs EK, Alawi MA, et al. Epidemiology and clinical consequences of occupational exposure to blood and other body fluids in a university hospital in Saudi Arabia. Saudi Med J. [Internet]. 2016 [cited Nov 02, 2018];37(7):783-90. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5018644/pdf/SaudiMedJ-37-783.pdf\n[https://www.ncbi.nlm.nih.gov/pmc/article...\n](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5018644/pdf/SaudiMedJ-37-783.pdf)-3838 Kocur E, \u015aliwa-Rak BO, Grosicki S. Analysis of occupational exposures to blood registered in the General Hospital in Zabrze in the years 2006-2015. Przegl Epidemiol. [Internet]. 2016 [cited Fev 12, 2018];70(4):603-15. Available from: http://www.przeglepidemiol.pzh.gov.pl/pobierz-artykul?id=2120. [http://www.przeglepidemiol.pzh.gov.pl/po...\n](http://www.przeglepidemiol.pzh.gov.pl/pobierz-artykul?id=2120)). Regarding age group, there was verified, in accordance with other researches(3939 Silva AR, Ferreira OC Jr, S\u00e1 RSA, Correia AL Jr, Silva SGC, Carvalho MAL Netto, et al. HBV and HCV serological markers in health professionals and users of the Brazilian Unified Health System network in the city of Resende, Rio de Janeiro, Brazil. J Bras Patol Med Lab. [Internet]. 2017 [cited Jan 22, 2018];53(2): 92-9. Available from: http://www.scielo.br/pdf/jbpml/v53n2/1676-2444-jbpml-53-02-0092.pdf\n[http://www.scielo.br/pdf/jbpml/v53n2/167...\n](http://www.scielo.br/pdf/jbpml/v53n2/1676-2444-jbpml-53-02-0092.pdf)-4040 Almeida MCM, Canini SRMS, Reis RK, Toffano SEM, Pereira FMV, Gir E. Clinical treatment adherence of health care workers and students exposed to potentially infectious biological material. Rev Esc Enferm USP. [Internet]. 2015 [cited Jun 22, 2018];49(2):259-64. Available from: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0080-62342015000200259&lng=en&nrm=iso&tlng=en\n[http://www.scielo.br/scielo.php?script=s...\n](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0080-62342015000200259&lng=en&nrm=iso&tlng=en)), higher prevalence of young adult workers.\nAs for the health team, the nursing team corresponds to the largest number of professionals in the health services, being the one who first assists the patient and is present from the admission to the discharge(4141 Conselho Federal de Enfermagem (BR), FIOCRUZ. Perfil da enfermagem no Brasil. [Internet]. Goi\u00e1s: COFEN; 2015. [Acesso 22 jun 2018]. Dispon\u00edvel em: http://www.cofen.gov.br/perfilenfermagem/pdfs/relatoriofinal.pdf\n[http://www.cofen.gov.br/perfilenfermagem...\n](http://www.cofen.gov.br/perfilenfermagem/pdfs/relatoriofinal.pdf)), is responsible for numerous procedures(4141 Conselho Federal de Enfermagem (BR), FIOCRUZ. Perfil da enfermagem no Brasil. [Internet]. Goi\u00e1s: COFEN; 2015. [Acesso 22 jun 2018]. Dispon\u00edvel em: http://www.cofen.gov.br/perfilenfermagem/pdfs/relatoriofinal.pdf\n[http://www.cofen.gov.br/perfilenfermagem...\n](http://www.cofen.gov.br/perfilenfermagem/pdfs/relatoriofinal.pdf)), which is why the higher incidence of accidents is inferred.\nAs identified in other researches(2121 Arantes MC, Haddad MCFL, Marcon SS, Rossaneis MA, Pissinati PSC, Oliveira SA. Occupational accidents with biological material among healthcare workers. Cogitare Enferm [Internet]. 2017 Jan-Mar [cited Jan 20, 2018];22(1):1-8. Available from: https://revistas.ufpr.br/cogitare/article/view/46508/pdf_en\n[https://revistas.ufpr.br/cogitare/articl...\n](https://revistas.ufpr.br/cogitare/article/view/46508/pdf_en),2929 Goel V, Kumar D, Lingaiah R, Singh S. Occurrence of needlestick and injuries among health-care workers of a tertiary care teaching hospital in North India. J Lab Physicians. [Internet]. 2017 Jan-Mar [cited Jun 2, 2018];9(1):20-5. Available from: http://www.jlponline.org/temp/JLabPhysicians9120-4059725_111637.pdf\n[http://www.jlponline.org/temp/JLabPhysic...\n](http://www.jlponline.org/temp/JLabPhysicians9120-4059725_111637.pdf),3737 Samargandy SA, Bukhari LM, Samargandy SA, Bahlas RS, Aldigs EK, Alawi MA, et al. Epidemiology and clinical consequences of occupational exposure to blood and other body fluids in a university hospital in Saudi Arabia. Saudi Med J. [Internet]. 2016 [cited Nov 02, 2018];37(7):783-90. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5018644/pdf/SaudiMedJ-37-783.pdf\n[https://www.ncbi.nlm.nih.gov/pmc/article...\n](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5018644/pdf/SaudiMedJ-37-783.pdf),4242 Santos EP Junior, Batista RRAM, Almeida ATF, Abreu RAA. Acidente de trabalho com material perfurocortante envolvendo profissionais e estudantes da \u00e1rea da sa\u00fade em hospital de refer\u00eancia. Rev Bras Med Trab. [Internet]. 2015 [Acesso 22 nov 2018];13(2):69-75. Dispon\u00edvel em: http://www.anamt.org.br/site/upload_arquivos/rbmt_volume_13_n%C2%BA_2_29320161552145795186.pdf\n[http://www.anamt.org.br/site/upload_arqu...\n](http://www.anamt.org.br/site/upload_arquivos/rbmt_volume_13_n%C2%BA_2_29320161552145795186.pdf)-4343 Bush C, Schmid K, Rupp ME, Watanabe-Galloway S, Wolford B, Sandkovsky U. Bloodborne pathogen exposures: difference in reporting rates and individual predictors among health care personnel. Am J Infect Control. 2017;45(4):372-6. doi: https://doi.org/10.1016/j.ajic.2016.11.028\n[https://doi.org/10.1016/j.ajic.2016.11.0...\n](https://doi.org/10.1016/j.ajic.2016.11.028)), in this study, it was identified that the most frequent object in accidents was the needle with and without lumen, therefore exposure to sharp objects prevailed, followed by exposure to mucous membranes. Exposures involving blood were the most numerous, as found in studies in the state of Goi\u00e1s(3636 Barros DX, Tipple AFV, Lima LKOL, Souza ACS, Neves ZCP, Salgado TA. Analysis of 10 years of accidents with biological material among the nursing staff. Rev Eletr Enferm. 2016;18:e1157. doi: http://dx.doi.org/10.5216/ree.v18.35493\n[http://dx.doi.org/10.5216/ree.v18.35493...\n](http://dx.doi.org/10.5216/ree.v18.35493),4444 Ream PS, Tipple AF, Salgado TA, Souza AC, Souza SM, Galdino-Junior H, et al. Hospital housekeepers: victims of ineffective hospital waste management. Arch Environ Occup Health. 2016;71(5):273-80. doi: https://doi.org/10.1080/19338244.2015.1089827\n[https://doi.org/10.1080/19338244.2015.10...\n](https://doi.org/10.1080/19338244.2015.1089827)), in other Brazilian states(66 Negrinho NBS, Malaguti-Toffano SE, Reis RK, Pereira FMV, Gir E. Factors associated with occupational exposure to biological material among nursing professionals. Rev Bras Enferm. [Internet]. 2017 [cited Jun 20, 2018];70(1): 126-31. Available from: http://www.scielo.br/pdf/reben/v70n1/en_0034-7167-reben-70-01-0133.pdf\n[http://www.scielo.br/pdf/reben/v70n1/en_...\n](http://www.scielo.br/pdf/reben/v70n1/en_0034-7167-reben-70-01-0133.pdf),2121 Arantes MC, Haddad MCFL, Marcon SS, Rossaneis MA, Pissinati PSC, Oliveira SA. Occupational accidents with biological material among healthcare workers. Cogitare Enferm [Internet]. 2017 Jan-Mar [cited Jan 20, 2018];22(1):1-8. Available from: https://revistas.ufpr.br/cogitare/article/view/46508/pdf_en\n[https://revistas.ufpr.br/cogitare/articl...\n](https://revistas.ufpr.br/cogitare/article/view/46508/pdf_en),4242 Santos EP Junior, Batista RRAM, Almeida ATF, Abreu RAA. Acidente de trabalho com material perfurocortante envolvendo profissionais e estudantes da \u00e1rea da sa\u00fade em hospital de refer\u00eancia. Rev Bras Med Trab. [Internet]. 2015 [Acesso 22 nov 2018];13(2):69-75. Dispon\u00edvel em: http://www.anamt.org.br/site/upload_arquivos/rbmt_volume_13_n%C2%BA_2_29320161552145795186.pdf\n[http://www.anamt.org.br/site/upload_arqu...\n](http://www.anamt.org.br/site/upload_arquivos/rbmt_volume_13_n%C2%BA_2_29320161552145795186.pdf)) and in other countries(77 Nouetchognou JS, Ateudjieu J, Jemea B, Mbanya D. Accidental exposures to blood and body fluids among health care workers in a Referral Hospital of Cameroon. BMC Res Notes. [Internet]. 2016 [cited Jul 10, 2018];9(94):1-6. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753641/pdf/13104_2016_Article_1923.pdf\n[https://www.ncbi.nlm.nih.gov/pmc/article...\n](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753641/pdf/13104_2016_Article_1923.pdf),2929 Goel V, Kumar D, Lingaiah R, Singh S. Occurrence of needlestick and injuries among health-care workers of a tertiary care teaching hospital in North India. J Lab Physicians. [Internet]. 2017 Jan-Mar [cited Jun 2, 2018];9(1):20-5. Available from: http://www.jlponline.org/temp/JLabPhysicians9120-4059725_111637.pdf\n[http://www.jlponline.org/temp/JLabPhysic...\n](http://www.jlponline.org/temp/JLabPhysicians9120-4059725_111637.pdf),3737 Samargandy SA, Bukhari LM, Samargandy SA, Bahlas RS, Aldigs EK, Alawi MA, et al. Epidemiology and clinical consequences of occupational exposure to blood and other body fluids in a university hospital in Saudi Arabia. Saudi Med J. [Internet]. 2016 [cited Nov 02, 2018];37(7):783-90. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5018644/pdf/SaudiMedJ-37-783.pdf\n[https://www.ncbi.nlm.nih.gov/pmc/article...\n](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5018644/pdf/SaudiMedJ-37-783.pdf)). Together, the data characterizes a population that should be the target of accident prevention campaigns and the need for investments in professional training to reduce biological occupational risk.\nAn essential preventive measure against HBV infection is vaccination, and the HCW needs to have it documented(1010 Centers for Disease Control and Prevention. CDC Guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management. MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports. [Internet]. 2013 [cited Nov 20, 2018];62(RR):1-22. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm\n[https://www.cdc.gov/mmwr/preview/mmwrhtm...\n](https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm),1313 Minist\u00e9rio da Sa\u00fade (BR). Protocolo cl\u00ednico e diretrizes terap\u00eauticas para profilaxia p\u00f3s-exposi\u00e7\u00e3o (pep) de risco \u00e0 infec\u00e7\u00e3o pelo HIV, IST, e hepatites virais. [Internet]. 2018 [Acesso 20 nov 2018]. Dispon\u00edvel em: http://www.aids.gov.br/pt-br/pub/2015/protocolo-clinico-e-diretrizes-terapeuticas-para-profilaxia-pos-exposicao-pep-de-risco\n[http://www.aids.gov.br/pt-br/pub/2015/pr...\n](http://www.aids.gov.br/pt-br/pub/2015/protocolo-clinico-e-diretrizes-terapeuticas-para-profilaxia-pos-exposicao-pep-de-risco)). Studies show vaccination frequencies against hepatitis B (three doses) of 73,5% to 97,5% among HCW, victims of biological material accident(2121 Arantes MC, Haddad MCFL, Marcon SS, Rossaneis MA, Pissinati PSC, Oliveira SA. Occupational accidents with biological material among healthcare workers. Cogitare Enferm [Internet]. 2017 Jan-Mar [cited Jan 20, 2018];22(1):1-8. Available from: https://revistas.ufpr.br/cogitare/article/view/46508/pdf_en\n[https://revistas.ufpr.br/cogitare/articl...\n](https://revistas.ufpr.br/cogitare/article/view/46508/pdf_en),2929 Goel V, Kumar D, Lingaiah R, Singh S. Occurrence of needlestick and injuries among health-care workers of a tertiary care teaching hospital in North India. J Lab Physicians. [Internet]. 2017 Jan-Mar [cited Jun 2, 2018];9(1):20-5. Available from: http://www.jlponline.org/temp/JLabPhysicians9120-4059725_111637.pdf\n[http://www.jlponline.org/temp/JLabPhysic...\n](http://www.jlponline.org/temp/JLabPhysicians9120-4059725_111637.pdf),3535 Cordeiro TMSC, Carneiro JN Neto, Cardoso MCB, Mattos AIS, Santos KOB, Ara\u00fajo TM. Occupational accidents with exposure to biological material: description of cases in Bahia. J Epidemiol Infect Control. [Internet]. 2016 [cited Dec 12, 2018];6(2):1-7. doi: http://dx.doi.org/10.17058/reci.v6i2.6218\n[http://dx.doi.org/10.17058/reci.v6i2.621...\n](http://dx.doi.org/10.17058/reci.v6i2.6218)), the vaccination rate of this study is in this range (85.1%), showing that policies to encourage and monitor the immunization of workers are, still, fundamental and deserve the attention of the managers.\nFollowing vaccination against hepatitis B, the performance of the anti-HBs test is essential for the safety of workers, as it will demonstrate the immunological status for the HBV(1010 Centers for Disease Control and Prevention. CDC Guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management. MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports. [Internet]. 2013 [cited Nov 20, 2018];62(RR):1-22. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm\n[https://www.cdc.gov/mmwr/preview/mmwrhtm...\n](https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm),1313 Minist\u00e9rio da Sa\u00fade (BR). Protocolo cl\u00ednico e diretrizes terap\u00eauticas para profilaxia p\u00f3s-exposi\u00e7\u00e3o (pep) de risco \u00e0 infec\u00e7\u00e3o pelo HIV, IST, e hepatites virais. [Internet]. 2018 [Acesso 20 nov 2018]. Dispon\u00edvel em: http://www.aids.gov.br/pt-br/pub/2015/protocolo-clinico-e-diretrizes-terapeuticas-para-profilaxia-pos-exposicao-pep-de-risco\n[http://www.aids.gov.br/pt-br/pub/2015/pr...\n](http://www.aids.gov.br/pt-br/pub/2015/protocolo-clinico-e-diretrizes-terapeuticas-para-profilaxia-pos-exposicao-pep-de-risco)). In Brazil, the rate of carrying out this test after primary vaccination in this group varied between 30.4%(4545 Martins AMEBL, Costa FM, Ferreira RC, Santos PE Neto, Magalhaes TA, S\u00e1 MAB, et al. Factors associated with immunization against Hepatitis B among workers of the Family Health Strategy Program. Rev Bras Enferm. [Internet]. 2015 Jan/Fev [cited Set 25, 2018];68(1): 77-84. Available from: http://www.scielo.br/pdf/reben/v68n1/en_0034-7167-reben-68-01-0084.pdf\n[http://www.scielo.br/pdf/reben/v68n1/en_...\n](http://www.scielo.br/pdf/reben/v68n1/en_0034-7167-reben-68-01-0084.pdf)); 27.9%(2323 Cavalcante MLR, Viana LS, Vasconcelos JO, Linhares MSC. Perfil dos acidentes de trabalho com exposi\u00e7\u00e3o a material biol\u00f3gico no munic\u00edpio de Sobral-Cear\u00e1, 2007 a 2014. Essentia. [Internet]. 2016 [Acesso 8 set 2018];17(2):1-22. Dispon\u00edvel em: http://www.uvanet.br/essentia/index.php/revistaessentia/article/view/75/84\n[http://www.uvanet.br/essentia/index.php/...\n](http://www.uvanet.br/essentia/index.php/revistaessentia/article/view/75/84)) and 4.1%(3636 Barros DX, Tipple AFV, Lima LKOL, Souza ACS, Neves ZCP, Salgado TA. Analysis of 10 years of accidents with biological material among the nursing staff. Rev Eletr Enferm. 2016;18:e1157. doi: http://dx.doi.org/10.5216/ree.v18.35493\n[http://dx.doi.org/10.5216/ree.v18.35493...\n](http://dx.doi.org/10.5216/ree.v18.35493)).\nThe anti-HBs test is not available in all hospitals for emergencies, as in the case of accidents with biological material(4646 Chang HH, Lee WK, Moon C, Choi WS, Yoon HJ, Kim J, et al. The acceptable duration between occupational exposure to hepatitis B virus and hepatitis B immunoglobulin injection: Results from a Korean nationwide, multicenter study. Am J Infect Control. 2016;44(2):189-93. doi: https://doi.org/10.1016/j.ajic.2015.08.024\n[https://doi.org/10.1016/j.ajic.2015.08.0...\n](https://doi.org/10.1016/j.ajic.2015.08.024)). At the reference units for this type of care, at the study site, blood samples are collected from the injured HCW for the performance of various serologies, including anti-HBs, and the results are delivered after 30 days. Despite the recommendation to perform this test in post-exposure management(1010 Centers for Disease Control and Prevention. CDC Guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management. MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports. [Internet]. 2013 [cited Nov 20, 2018];62(RR):1-22. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm\n[https://www.cdc.gov/mmwr/preview/mmwrhtm...\n](https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm),1313 Minist\u00e9rio da Sa\u00fade (BR). Protocolo cl\u00ednico e diretrizes terap\u00eauticas para profilaxia p\u00f3s-exposi\u00e7\u00e3o (pep) de risco \u00e0 infec\u00e7\u00e3o pelo HIV, IST, e hepatites virais. [Internet]. 2018 [Acesso 20 nov 2018]. Dispon\u00edvel em: http://www.aids.gov.br/pt-br/pub/2015/protocolo-clinico-e-diretrizes-terapeuticas-para-profilaxia-pos-exposicao-pep-de-risco\n[http://www.aids.gov.br/pt-br/pub/2015/pr...\n](http://www.aids.gov.br/pt-br/pub/2015/protocolo-clinico-e-diretrizes-terapeuticas-para-profilaxia-pos-exposicao-pep-de-risco)), its performance in this study was low (44.6%), as shown in other studies in Brazil, in which the rate of anti-HBs testing among HCW exposed to biological material, in the accident time, ranged from 14.6% to 52.8%(2121 Arantes MC, Haddad MCFL, Marcon SS, Rossaneis MA, Pissinati PSC, Oliveira SA. Occupational accidents with biological material among healthcare workers. Cogitare Enferm [Internet]. 2017 Jan-Mar [cited Jan 20, 2018];22(1):1-8. Available from: https://revistas.ufpr.br/cogitare/article/view/46508/pdf_en\n[https://revistas.ufpr.br/cogitare/articl...\n](https://revistas.ufpr.br/cogitare/article/view/46508/pdf_en)\n22 Garbin CAS, Wakayama B, Dias IA, Bertocello LM, Garbin AJI. Hepatitis B and occupational exposure in the dental setting. The valuation of the knowledge and professionals attitudes. J Health Sci. [Internet]. 2017 [cited Ago 18, 2018];19(2):209-13. Available from: http://pgsskroton.com.br/seer/index.php/JHealthSci/article/view/5053/3683\n[http://pgsskroton.com.br/seer/index.php/...\n](http://pgsskroton.com.br/seer/index.php/JHealthSci/article/view/5053/3683)-2323 Cavalcante MLR, Viana LS, Vasconcelos JO, Linhares MSC. Perfil dos acidentes de trabalho com exposi\u00e7\u00e3o a material biol\u00f3gico no munic\u00edpio de Sobral-Cear\u00e1, 2007 a 2014. Essentia. [Internet]. 2016 [Acesso 8 set 2018];17(2):1-22. Dispon\u00edvel em: http://www.uvanet.br/essentia/index.php/revistaessentia/article/view/75/84\n[http://www.uvanet.br/essentia/index.php/...\n](http://www.uvanet.br/essentia/index.php/revistaessentia/article/view/75/84),3030 Sistema de Vigil\u00e2ncia de Acidentes de Trabalho com material biol\u00f3gico em servi\u00e7os de sa\u00fade brasileiros (BR). Relat\u00f3rio PSBio. 1\u00aa fase: 2002 a 2004, 2\u00aa fase: 2005 a 2015. [Internet]. Rio de Janeiro: PSBio; 2015. [Acesso 2 jun 2018];1-21. Dispon\u00edvel em: https://www.riscobiologico.org/psbio/psbio_201505.pdf\n[https://www.riscobiologico.org/psbio/psb...\n](https://www.riscobiologico.org/psbio/psbio_201505.pdf)-3131 Santos SS, Costa NA, Mascarenhas MDM. Caracteriza\u00e7\u00e3o das exposi\u00e7\u00f5es ocupacionais a material biol\u00f3gico entre trabalhadores de hospitais no Munic\u00edpio de Teresina, Estado do Piau\u00ed, Brasil, 2007 a 2011. Epidemiol Serv Sa\u00fade. [Internet]. 2013 Jan-Mar [Acesso 12 dez 2018];22(1):165-70. Dispon\u00edvel em: http://scielo.iec.gov.br/pdf/ess/v22n1/v22n1a17.pdf\n[http://scielo.iec.gov.br/pdf/ess/v22n1/v...\n](http://scielo.iec.gov.br/pdf/ess/v22n1/v22n1a17.pdf),4747 Pinelli C, Neri SN, Loffredo LCM. Dental students\u2019 reports of occupational exposures to potentially infectious biological material in a Brazilian School of Dentistry. Cad Sa\u00fade Colet. [Internet]. 2016 [cited Jan 21, 2018];24(2):162-9. Available from: http://www.scielo.br/pdf/cadsc/v24n2/1414-462X-cadsc-24-2-162.pdf\n[http://www.scielo.br/pdf/cadsc/v24n2/141...\n](http://www.scielo.br/pdf/cadsc/v24n2/1414-462X-cadsc-24-2-162.pdf)).\nRegarding the serologic status of the source-person for HBsAg positive, a rate of 1.8% (95% CI 1.0 - 3.2) was observed in this study. Rate of 0.5% to 1.4%(2121 Arantes MC, Haddad MCFL, Marcon SS, Rossaneis MA, Pissinati PSC, Oliveira SA. Occupational accidents with biological material among healthcare workers. Cogitare Enferm [Internet]. 2017 Jan-Mar [cited Jan 20, 2018];22(1):1-8. Available from: https://revistas.ufpr.br/cogitare/article/view/46508/pdf_en\n[https://revistas.ufpr.br/cogitare/articl...\n](https://revistas.ufpr.br/cogitare/article/view/46508/pdf_en),3030 Sistema de Vigil\u00e2ncia de Acidentes de Trabalho com material biol\u00f3gico em servi\u00e7os de sa\u00fade brasileiros (BR). Relat\u00f3rio PSBio. 1\u00aa fase: 2002 a 2004, 2\u00aa fase: 2005 a 2015. [Internet]. Rio de Janeiro: PSBio; 2015. [Acesso 2 jun 2018];1-21. Dispon\u00edvel em: https://www.riscobiologico.org/psbio/psbio_201505.pdf\n[https://www.riscobiologico.org/psbio/psb...\n](https://www.riscobiologico.org/psbio/psbio_201505.pdf)-3131 Santos SS, Costa NA, Mascarenhas MDM. Caracteriza\u00e7\u00e3o das exposi\u00e7\u00f5es ocupacionais a material biol\u00f3gico entre trabalhadores de hospitais no Munic\u00edpio de Teresina, Estado do Piau\u00ed, Brasil, 2007 a 2011. Epidemiol Serv Sa\u00fade. [Internet]. 2013 Jan-Mar [Acesso 12 dez 2018];22(1):165-70. Dispon\u00edvel em: http://scielo.iec.gov.br/pdf/ess/v22n1/v22n1a17.pdf\n[http://scielo.iec.gov.br/pdf/ess/v22n1/v...\n](http://scielo.iec.gov.br/pdf/ess/v22n1/v22n1a17.pdf)) were identified in the literature.\nIn Scenario A (\n[Figure 1]()), it was observed that four HCW with anti-HBs <10 IU/ml were exposed to HBsAg positive source-person; therefore the conduct recommended by the CDC(1010 Centers for Disease Control and Prevention. CDC Guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management. MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports. [Internet]. 2013 [cited Nov 20, 2018];62(RR):1-22. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm\n[https://www.cdc.gov/mmwr/preview/mmwrhtm...\n](https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm)) is the administration of one dose of IGHAHB and one dose of the vaccine, simultaneously and as soon as possible, as the efficacy of IGHAHB, when administered after seven days of exposure, is unknown(1010 Centers for Disease Control and Prevention. CDC Guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management. MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports. [Internet]. 2013 [cited Nov 20, 2018];62(RR):1-22. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm\n[https://www.cdc.gov/mmwr/preview/mmwrhtm...\n](https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm)). In this case, the direct cost of this group was US $ 1,109.08, corresponding to US $ 277.27 per worker. The direct cost could have been avoided with the second vaccination schedule followed by the anti-HBs test, as probably the number of HCW with anti-HBs <10 IU/ mL would be lower, since the worker can respond to a second schedule(1010 Centers for Disease Control and Prevention. CDC Guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management. MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports. [Internet]. 2013 [cited Nov 20, 2018];62(RR):1-22. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm\n[https://www.cdc.gov/mmwr/preview/mmwrhtm...\n](https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm)).\nThe health protection of the HBP-related HCW is very explicit in Collegiate Board Resolution No. 11, which provides for the requirements of good operating practices for dialysis services, as it prohibits workers without protective titles to HBV, to carry out assistance during the session of hemodialysis and, in the processing of dialyzers and arterial and venous lines of patients with positive serology for hepatitis B(4848 Minist\u00e9rio da Sa\u00fade (BR). Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria. Resolu\u00e7\u00e3o RDC n\u00ba 11 de 13 de mar\u00e7o de 2014. Disp\u00f5e sobre os Requisitos de Boas Pr\u00e1ticas de Funcionamento para os Servi\u00e7os de Di\u00e1lise e d\u00e1 outras provid\u00eancias. [Internet]. [Acesso 20 jan 2018]. Dispon\u00edvelem:http://portal.anvisa.gov.br/documents/10181/2867923/(1)RDC_11_2014_COMP.pdf/5e552d92-f573-4c54-8cab-b06efa87036e\n[http://portal.anvisa.gov.br/documents/10...\n](http://portal.anvisa.gov.br/documents/10181/2867923/(1)RDC_11_2014_COMP.pdf/5e552d92-f573-4c54-8cab-b06efa87036e)). However, this regulation does not apply to other areas of care, which also offer risk of contact with blood from HBV-positive patients; then it is considered necessary to encourage the performance of anti-HBs testing among all HCW.\nConsidering the prevention for HBV, it is interesting to note that NR 32/2005 ensures that all HCW should be provided with the hepatitis B vaccine, free of charge, with the employer must keep supporting document and keep it available for labor inspection. However, when it comes to anti-HBs testing, the standard is not so clear. Declares that the employer must monitor the effectiveness whenever recommended by the Ministry of Health and, when necessary, provide the vaccine booster(2020 Minist\u00e9rio do Trabalho e Emprego (BR). Portaria n.\u00ba 485, de 11 de novembro de 2005. NR 32- Seguran\u00e7a e Sa\u00fade no Trabalho em Servi\u00e7os de Sa\u00fade. [Internet]. 2005 [Acesso 20 jan 2018]. Dispon\u00edvel em: https://www20.anvisa.gov.br/segurancadopaciente/index.php/legislacao/item/portaria-n-485-de-11-de-novembro-de-2005\n[https://www20.anvisa.gov.br/segurancadop...\n](https://www20.anvisa.gov.br/segurancadopaciente/index.php/legislacao/item/portaria-n-485-de-11-de-novembro-de-2005)).\nAlthough the vaccine is provided free by SUS, in this study, it was observed that there are still HCW without vaccination, according to scenario B (\n[Figure 2]()). Therefore, it would be important for managers to provide effective strategies to ensure vaccine completion for workers prior to admission to the health service(4949 Neves ZCP, Tipple AFV, Mendon\u00e7a KM, Souza ACS, Pereira MS. Brazilian legislation and recommendations related to occupational health and safety of health workers. Rev Eletr Enferm. [Internet]. 2017 [cited Jun 11, 2018];19:a01. Available from: https://revistas.ufg.br/fen/article/view/40427/22827\n[https://revistas.ufg.br/fen/article/view...\n](https://revistas.ufg.br/fen/article/view/40427/22827)).\nIn scenario B (\n[Figure 2]()), HCW not vaccinated against hepatitis B were analyzed. These workers who had an accident with a positive HBsAg source-person had a high cost to the health system, as well as those who had an unknown source-person accident. However, scenario D ( [Figure 4]()) in which the test was performed before exposure was the one with the lowest cost when compared to the other scenarios.\nConsequently, when comparing the per capita cost of scenario A (\n[Figure 1]()) in which the HCW vaccinated with the anti-HBs test <10 IU/mL was exposed to HBsAg-positive source-person with the scenario D ( [Figure 4]()) of the vaccinated worker and with the anti-HBs test >10 IU/mL after hepatitis B vaccine before the accident with biological material, it was noted that the first cost was about 32 times more expensive for SUS ( [Table 1]()). Thus, the opportunity to allocate resources to other programs, including those aimed at the health of the own workers, is lost(2020 Minist\u00e9rio do Trabalho e Emprego (BR). Portaria n.\u00ba 485, de 11 de novembro de 2005. NR 32- Seguran\u00e7a e Sa\u00fade no Trabalho em Servi\u00e7os de Sa\u00fade. [Internet]. 2005 [Acesso 20 jan 2018]. Dispon\u00edvel em: https://www20.anvisa.gov.br/segurancadopaciente/index.php/legislacao/item/portaria-n-485-de-11-de-novembro-de-2005\n[https://www20.anvisa.gov.br/segurancadop...\n](https://www20.anvisa.gov.br/segurancadopaciente/index.php/legislacao/item/portaria-n-485-de-11-de-novembro-de-2005)).\nWhen comparing the per capita cost of the HCW vaccinated with the anti-HBs test <10 IU/ml (scenario A -\n[Figure 1]()) who had an accident with an unknown source-person with a worker vaccinated with anti-HBs after primary vaccination (scenario D - [Figure 4]()), the cost was approximately 31 times higher. As well, when checking the per capita cost of the HCW vaccinated with the anti-HBs test <10 IU \\/ ml (scenario A - [Figure 1]()) exposed to HBsAg-negative source-person with the worker vaccinated with anti-HBs primary vaccination (scenario D - [Figure 4]()), the cost was in about twice as expensive for SUS.\nIn cases of post-exposure management of unvaccinated HCW (scenario B -\n[Figure 2]()), the per capita costs were elevated when compared also to the worker vaccinated with anti-HBs after primary vaccination (scenario D - [Figure 4]()), being 32 times more expensive for SUS when the SAD was exposed to HBsAg-positive source-person and 31 times higher when the person-source was unknown.\nWhen comparing the per capita cost of vaccinated HCW and with anti-HBs <10 IU/ml exposed to HBsAg-positive source-person (scenario C -\n[Figure 3]()) with the cost of the worker vaccinated with anti-HBs after primary vaccination (scenario D - [Figure 4]()), the cost was around 32 times higher for SUS. Still in the scenario C ( [Figure 3]()), when comparing the per capita cost of HCW with negative anti-HBs exposed to unknown source-person with the worker\u2019s cost vaccinated with anti-HBs after primary vaccination (scenario D - [Figure 4]()), the cost was 31 times more costly for SUS.\nA Brazilian study showed that HBV infection has high costs for the health system, with an average annual cost per patient of U $ 117 to 11,488 depending on medication(22 Wiens A, Lenzi L, Venson R, Pedroso ML, Correr CJ, Pontarolo R. Economic evaluation of treatments for chronic hepatitis B. Braz J Infect Dis. 2013;17(4): 418-26. doi: https://doi.org/10.1016/j.bjid.2012.12.005\n[https://doi.org/10.1016/j.bjid.2012.12.0...\n](https://doi.org/10.1016/j.bjid.2012.12.005)), without mentioning the costs of carrying out tests for the clinical and laboratory monitoring of the injured worker. The cost for treating hepatitis B is also high in other countries(5050 Robotin M, Patton Y, Kansil M, Penman A, George J. Cost of treating chronic hepatitis B: comparison of current treatment guidelines. World J Gastroenterol. [Internet]. 2012 [cited Jan 15, 2018];18(42):6106-13. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496887/pdf/WJG-18-6106.pdf\n[https://www.ncbi.nlm.nih.gov/pmc/article...\n](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496887/pdf/WJG-18-6106.pdf)-5151 Banerjee S, Gunda P, Drake RF, Hamed K. Telbivudine for the treatment of chronic hepatitis B in HBeAg-positive patients in China: a health economic analysis. [Internet]. Springerplus. 2016 [cited Nov 25, 2018];5(1):1719. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052247/pdf/40064_2016_Article_3404.pdf\n[https://www.ncbi.nlm.nih.gov/pmc/article...\n](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052247/pdf/40064_2016_Article_3404.pdf)).\nTherefore, when the health system pays for preventable disease treatments, the opportunity to invest in effective prevention and promotion measures is lost(5252 Oliveira ML, Santos LMP, Silva EN. Bases metodol\u00f3gicas para estudos de custos da doen\u00e7a no Brasil. Rev Nutr. [Internet]. 2014 [Acesso 5 jun 2018];27:585-95. Dispon\u00edvel em: http://www.scielo.br/pdf/rn/v27n5/1415-5273-rn-27-05-00585.pdf\n[http://www.scielo.br/pdf/rn/v27n5/1415-5...\n](http://www.scielo.br/pdf/rn/v27n5/1415-5273-rn-27-05-00585.pdf)). Such analysis can be performed through the opportunity cost, which represents the cost of losing the opportunity to apply financial resources in other health technologies or programs that have a positive impact on public health(5353 Drummond MF, Sculpher MJ, Torrance GW, O\u2019Brien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press; 2005.).\nThis study showed that the allocation of SUS resources to preventive measures, including the provision and monitoring of anti-HBs tests to all HCW, is more economical than post-exposure management and these data can support public policies on worker health, ensuring greater security at a lower cost. Some gaps found in the SINAN-NET database were its limitation.\nConclusion\nThe direct cost of post-exposure prophylaxis for SUS was about 30 times more expensive than the costs of post-vaccination testing in those accidents in which the source-person was positive or unknown and the professional had unknown anti-HBs.\nScenarios A (branch three and four), scenario B (branch six and seven) and scenario C (branch 10 and 11) for post-exposure management to HBV when compared to scenario D, which represents the primary vaccination followed by confirmation of immunity confirmed by the anti-HBs test, showed greater per capita cost impact.\nHealth managers can rely on the findings of this study for the implementation of the routine of carrying out the post-vaccination anti-HBs test, ensuring greater protection to the health of the worker with a reduction in the costs of post-exposure management related to HBV, optimizing scarce public resources in our country.\n-\n*\nPaper extracted from master\u00b4s thesis \u201cThe cost of primary post-vaccination anti-HBs testing in relation to Hepatitis B post-exposure practices among health care workers\u201d, presented to Universidade Federal de Goi\u00e1s, Faculdade de Enfermagem, Goi\u00e2nia, GO, Brazil.\nReferences\n-\n1World Health Organization. Global hepatitis report 2017. [Internet]. Geneva: World Health Organization; 2017. [cited April 13, 2018]. Available from: https://apps.who.int/iris/bitstream/handle/10665/255016/9789241565455eng.pdf;jsessionid=0DA6245F73DE62CA74AFDA377EDEAAC9?sequence=1\n[\u00bb https://apps.who.int/iris/bitstream/handle/10665/255016/9789241565455eng.pdf;jsessionid=0DA6245F73DE62CA74AFDA377EDEAAC9?sequence=1](https://apps.who.int/iris/bitstream/handle/10665/255016/9789241565455eng.pdf;jsessionid=0DA6245F73DE62CA74AFDA377EDEAAC9?sequence=1)\n-\n2Wiens A, Lenzi L, Venson R, Pedroso ML, Correr CJ, Pontarolo R. Economic evaluation of treatments for chronic hepatitis B. Braz J Infect Dis. 2013;17(4): 418-26. doi: https://doi.org/10.1016/j.bjid.2012.12.005\n[\u00bb https://doi.org/10.1016/j.bjid.2012.12.005](https://doi.org/10.1016/j.bjid.2012.12.005)\n-\n3Zhang S, Ma Q, Liang S, Xiao H, Zhuang G, Zou Y, et al. Annual economic burden of hepatitis B virus-related diseases among hospitalized patients in twelve cities in China. J Viral Hepat. 2016;23(3):202-10. doi: https://doi.org/10.1111/jvh.12482\n[\u00bb https://doi.org/10.1111/jvh.12482](https://doi.org/10.1111/jvh.12482)\n-\n4Minist\u00e9rio da Sa\u00fade (BR). Boletim epidemiol\u00f3gico de hepatites virais. [Internet]. 2019. [Acesso 20 out 2019]. Dispon\u00edvel em: http://www.aids.gov.br/pt-br/pub/2019/boletim-epidemiologico-de-hepatites-virais-2019\n[\u00bb http://www.aids.gov.br/pt-br/pub/2019/boletim-epidemiologico-de-hepatites-virais-2019](http://www.aids.gov.br/pt-br/pub/2019/boletim-epidemiologico-de-hepatites-virais-2019)\n-\n5Carvalho DC, Rocha JC, Gimenes MCA, Santos EC, Valim MD. Work incidents with biological material in the nursing team of a hospital in Mid-Western Brazil. Esc Anna Nery. [Internet]. 2018 [cited Apr 20, 2018];22(1): 1-8. Available from: http://www.scielo.br/pdf/ean/v22n1/1414-8145-ean-2177-9465-EAN-2017-0140.pdf\n[\u00bb http://www.scielo.br/pdf/ean/v22n1/1414-8145-ean-2177-9465-EAN-2017-0140.pdf](http://www.scielo.br/pdf/ean/v22n1/1414-8145-ean-2177-9465-EAN-2017-0140.pdf)\n-\n6Negrinho NBS, Malaguti-Toffano SE, Reis RK, Pereira FMV, Gir E. Factors associated with occupational exposure to biological material among nursing professionals. Rev Bras Enferm. [Internet]. 2017 [cited Jun 20, 2018];70(1): 126-31. Available from: http://www.scielo.br/pdf/reben/v70n1/en_0034-7167-reben-70-01-0133.pdf\n[\u00bb http://www.scielo.br/pdf/reben/v70n1/en_0034-7167-reben-70-01-0133.pdf](http://www.scielo.br/pdf/reben/v70n1/en_0034-7167-reben-70-01-0133.pdf)\n-\n7Nouetchognou JS, Ateudjieu J, Jemea B, Mbanya D. Accidental exposures to blood and body fluids among health care workers in a Referral Hospital of Cameroon. BMC Res Notes. [Internet]. 2016 [cited Jul 10, 2018];9(94):1-6. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753641/pdf/13104_2016_Article_1923.pdf\n[\u00bb https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753641/pdf/13104_2016_Article_1923.pdf](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753641/pdf/13104_2016_Article_1923.pdf)\n-\n8Garus-Pakowska A, G\u00f3rajski M, Szatko F. Awareness of the risk of exposure to infectious material and the behaviors of Polish paramedics with respect to the hazards from blood-borne pathogens - a nationwide study. Int J Environ Res Public Health. [Internet]. 2017 [cited Ago 10, 2018];14(843):1-9. doi: 10.3390/ijerph14080843\n[\u00bb https://doi.org/10.3390/ijerph14080843](https://doi.org/10.3390/ijerph14080843)\n-\n9Matsubara C, Sakisaka K, Sychareun V, Phensavanh A, Ali M. Prevalence and risk factors of needle stick and sharp injury among tertiary hospital workers, Vientiane, Lao PDR. Occup Health. [Internet]. 2017 [cited Nov 20, 2018];59(6):581-5. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721280/pdf/1348-9585-59-581.pdf\n[\u00bb https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721280/pdf/1348-9585-59-581.pdf](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721280/pdf/1348-9585-59-581.pdf)\n-\n10Centers for Disease Control and Prevention. CDC Guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management. MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports. [Internet]. 2013 [cited Nov 20, 2018];62(RR):1-22. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm\n[\u00bb https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm](https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm)\n-\n11Minist\u00e9rio da Sa\u00fade (BR). Programa Nacional de Imuniza\u00e7\u00f5es (PNI): 40 anos. [Internet]. 2013 [Acesso 20 mar 2018]. Dispon\u00edvel em: http://bvsms.saude.gov.br/bvs/publicacoes/programa_nacional_imunizacoes_pni40.pdf\n[\u00bb http://bvsms.saude.gov.br/bvs/publicacoes/programa_nacional_imunizacoes_pni40.pdf](http://bvsms.saude.gov.br/bvs/publicacoes/programa_nacional_imunizacoes_pni40.pdf)\n-\n12Averhoff F, Mahoney F, Coleman P, Schatz G, Hurwitz E, Margolis H. Immunogenicity of hepatitis B Vaccines. Implications for persons at occupational risk of hepatitis B virus infection. Am J Prev Med. [Internet]. 1998 [cited Nov 20, 2018];15(1):1-8. doi: https://doi.org/10.1016/S0749-3797(98)00003-8\n[\u00bb https://doi.org/10.1016/S0749-3797(98)00003-8](https://doi.org/10.1016/S0749-3797(98)00003-8)\n-\n13Minist\u00e9rio da Sa\u00fade (BR). Protocolo cl\u00ednico e diretrizes terap\u00eauticas para profilaxia p\u00f3s-exposi\u00e7\u00e3o (pep) de risco \u00e0 infec\u00e7\u00e3o pelo HIV, IST, e hepatites virais. [Internet]. 2018 [Acesso 20 nov 2018]. Dispon\u00edvel em: http://www.aids.gov.br/pt-br/pub/2015/protocolo-clinico-e-diretrizes-terapeuticas-para-profilaxia-pos-exposicao-pep-de-risco\n[\u00bb http://www.aids.gov.br/pt-br/pub/2015/protocolo-clinico-e-diretrizes-terapeuticas-para-profilaxia-pos-exposicao-pep-de-risco](http://www.aids.gov.br/pt-br/pub/2015/protocolo-clinico-e-diretrizes-terapeuticas-para-profilaxia-pos-exposicao-pep-de-risco)\n-\n14O\u2019Malley EM, Scott RD 2nd, Gayle J, Dekutoski J, Foltzer M, Lundstrom TS, et al. Costs of management of occupational exposures to blood and body fluids. Infect Control Hosp Epidemiol. 2007;28(7):774-82. doi: https://doi.org/10.1086/518729\n[\u00bb https://doi.org/10.1086/518729](https://doi.org/10.1086/518729)\n-\n15Oh HS, Yoon Chang SW, Choi JS, Park ES, Jin HY. Costs of postexposure management of occupational sharps injuries in health care workers in the Republic of Korea. Am J Infect Control. 2013;41(1):61-5. doi: https://doi.org/10.1016/j.ajic.2012.01.030\n[\u00bb https://doi.org/10.1016/j.ajic.2012.01.030](https://doi.org/10.1016/j.ajic.2012.01.030)\n-\n16Lee JM, Botteman MF, Xanthakos N, Nicklasson L. Needlestick injuries in the United States. Epidemiologic, economic, and quality of life issues. AAOHN J. [Internet]. 2005 [cited Nov 20, 2018];53(3):117-33. Available from: https://www.ncbi.nlm.nih.gov/pubmed/15789967\n[\u00bb https://www.ncbi.nlm.nih.gov/pubmed/15789967](https://www.ncbi.nlm.nih.gov/pubmed/15789967)\n-\n17Leigh JP, Gillen M, Franks P, Sutherland S, Nguyen HH, Steenland K, et al. Costs of needlestick injuries and subsequent hepatitis and HIV infection. Curr Med Res Opin. 2007;23(9):2093-105. doi: https://doi.org/10.1185/030079907X219517\n[\u00bb https://doi.org/10.1185/030079907X219517](https://doi.org/10.1185/030079907X219517)\n-\n18Mannocci A, De Carli G, Di Bari V, Saulle R, Unim B, Nicolotti N, et al. How much do needlestick injuries cost? A systematic review of the economic evaluations of needlestick and sharps injuries among healthcare personnel. Infect Control Hosp Epidemiol. 2016;37(6):635-46. doi: https://doi.org/10.1017/ice.2016.48\n[\u00bb https://doi.org/10.1017/ice.2016.48](https://doi.org/10.1017/ice.2016.48)\n-\n19Minist\u00e9rio da Sa\u00fade (BR). Recomenda\u00e7\u00f5es para terapia antirretroviral em adultos infectados pelo HIV- 2008. Suplemento III - Tratamento e preven\u00e7\u00e3o. [Internet]. 2010. [Acesso 10 jan 2017]. Dispon\u00edvel em: http://www.aids.gov.br/sites/default/files/pub/2016/59204/suplemento_consenso_adulto_01_24_01_2011_web_pdf_13627.pdf\n[\u00bb http://www.aids.gov.br/sites/default/files/pub/2016/59204/suplemento_consenso_adulto_01_24_01_2011_web_pdf_13627.pdf](http://www.aids.gov.br/sites/default/files/pub/2016/59204/suplemento_consenso_adulto_01_24_01_2011_web_pdf_13627.pdf)\n-\n20Minist\u00e9rio do Trabalho e Emprego (BR). Portaria n.\u00ba 485, de 11 de novembro de 2005. NR 32- Seguran\u00e7a e Sa\u00fade no Trabalho em Servi\u00e7os de Sa\u00fade. [Internet]. 2005 [Acesso 20 jan 2018]. Dispon\u00edvel em: https://www20.anvisa.gov.br/segurancadopaciente/index.php/legislacao/item/portaria-n-485-de-11-de-novembro-de-2005\n[\u00bb https://www20.anvisa.gov.br/segurancadopaciente/index.php/legislacao/item/portaria-n-485-de-11-de-novembro-de-2005](https://www20.anvisa.gov.br/segurancadopaciente/index.php/legislacao/item/portaria-n-485-de-11-de-novembro-de-2005)\n-\n21Arantes MC, Haddad MCFL, Marcon SS, Rossaneis MA, Pissinati PSC, Oliveira SA. Occupational accidents with biological material among healthcare workers. Cogitare Enferm [Internet]. 2017 Jan-Mar [cited Jan 20, 2018];22(1):1-8. Available from: https://revistas.ufpr.br/cogitare/article/view/46508/pdf_en\n[\u00bb https://revistas.ufpr.br/cogitare/article/view/46508/pdf_en](https://revistas.ufpr.br/cogitare/article/view/46508/pdf_en)\n-\n22Garbin CAS, Wakayama B, Dias IA, Bertocello LM, Garbin AJI. Hepatitis B and occupational exposure in the dental setting. The valuation of the knowledge and professionals attitudes. J Health Sci. [Internet]. 2017 [cited Ago 18, 2018];19(2):209-13. Available from: http://pgsskroton.com.br/seer/index.php/JHealthSci/article/view/5053/3683\n[\u00bb http://pgsskroton.com.br/seer/index.php/JHealthSci/article/view/5053/3683](http://pgsskroton.com.br/seer/index.php/JHealthSci/article/view/5053/3683)\n-\n23Cavalcante MLR, Viana LS, Vasconcelos JO, Linhares MSC. Perfil dos acidentes de trabalho com exposi\u00e7\u00e3o a material biol\u00f3gico no munic\u00edpio de Sobral-Cear\u00e1, 2007 a 2014. Essentia. [Internet]. 2016 [Acesso 8 set 2018];17(2):1-22. Dispon\u00edvel em: http://www.uvanet.br/essentia/index.php/revistaessentia/article/view/75/84\n[\u00bb http://www.uvanet.br/essentia/index.php/revistaessentia/article/view/75/84](http://www.uvanet.br/essentia/index.php/revistaessentia/article/view/75/84)\n-\n24Silva EN, Silva MT, Pereira MG. Identifying, measuring and valuing health costs. Epidemiol Serv Sa\u00fade. [Internet]. 2016 Abr-Jun [cited Feb 20, 2018];25(2): 437-9. Available from: http://scielo.iec.gov.br/pdf/ess/v25n2/2237-9622-ess-25-02-00437.pdf\n[\u00bb http://scielo.iec.gov.br/pdf/ess/v25n2/2237-9622-ess-25-02-00437.pdf](http://scielo.iec.gov.br/pdf/ess/v25n2/2237-9622-ess-25-02-00437.pdf)\n-\n25Minist\u00e9rio da Sa\u00fade (BR). Secretaria de Ci\u00eancia, Tecnologia e Insumos Estrat\u00e9gicos. Departamento de Ci\u00eancia e Tecnologia. Diretrizes metodol\u00f3gicas: diretriz de avalia\u00e7\u00e3o econ\u00f4mica. [Internet]. 2014. [Acesso 20 jan 2018]. Dispon\u00edvel em: http://bvsms.saude.gov.br/bvs/publicacoes/diretrizes_metodologicas_diretriz_avaliacao_economica.pdf\n[\u00bb http://bvsms.saude.gov.br/bvs/publicacoes/diretrizes_metodologicas_diretriz_avaliacao_economica.pdf](http://bvsms.saude.gov.br/bvs/publicacoes/diretrizes_metodologicas_diretriz_avaliacao_economica.pdf)\n-\n26Silva EN, Silva MT, Pereira MG. Health economic evaluation studies: definition and applicability to health systems and services. Epidemiol Serv Sa\u00fade. [Internet]. 2016 Jan/Mar [cited Fev 20, 2018];25:(1):205-7. Available from: http://scielo.iec.gov.br/pdf/ess/v25n1/v25n1a23.pdf\n[\u00bb http://scielo.iec.gov.br/pdf/ess/v25n1/v25n1a23.pdf](http://scielo.iec.gov.br/pdf/ess/v25n1/v25n1a23.pdf)\n-\n27Instituto Brasileiro de Geografia Estat\u00edstica. Estimativas de popula\u00e7\u00e3o. Estimativas da popula\u00e7\u00e3o residente no Brasil e unidades da Federa\u00e7\u00e3o com data de refer\u00eancia em 1\u00ba de julho de 2017. [Internet] 2017. [Acesso 10 jan 2020]. Dispon\u00edvel em: ftp://ftp.ibge.gov.br/Estimativas_de_Populacao/Estimativas_2017\n[\u00bb ftp://ftp.ibge.gov.br/Estimativas_de_Populacao/Estimativas_2017](ftp://ftp.ibge.gov.br/Estimativas_de_Populacao/Estimativas_2017)\n-\n28Minist\u00e9rio da Sa\u00fade (BR). Cadastro Nacional de Estabelecimentos de Sa\u00fade. CNESnet - Secretaria de Aten\u00e7\u00e3o \u00e0 Sa\u00fade DATASUS. Estabelecimentos cadastrados no Estado Goi\u00e1s. [Internet] 2017. [Acesso 10 jan 2020]. Dispon\u00edvel em: http://cnes.datasus.gov.br/pages/estabelecimentos/consulta.jsp\n[\u00bb http://cnes.datasus.gov.br/pages/estabelecimentos/consulta.jsp](http://cnes.datasus.gov.br/pages/estabelecimentos/consulta.jsp)\n-\n29Goel V, Kumar D, Lingaiah R, Singh S. Occurrence of needlestick and injuries among health-care workers of a tertiary care teaching hospital in North India. J Lab Physicians. [Internet]. 2017 Jan-Mar [cited Jun 2, 2018];9(1):20-5. Available from: http://www.jlponline.org/temp/JLabPhysicians9120-4059725_111637.pdf\n[\u00bb http://www.jlponline.org/temp/JLabPhysicians9120-4059725_111637.pdf](http://www.jlponline.org/temp/JLabPhysicians9120-4059725_111637.pdf)\n-\n30Sistema de Vigil\u00e2ncia de Acidentes de Trabalho com material biol\u00f3gico em servi\u00e7os de sa\u00fade brasileiros (BR). Relat\u00f3rio PSBio. 1\u00aa fase: 2002 a 2004, 2\u00aa fase: 2005 a 2015. [Internet]. Rio de Janeiro: PSBio; 2015. [Acesso 2 jun 2018];1-21. Dispon\u00edvel em: https://www.riscobiologico.org/psbio/psbio_201505.pdf\n[\u00bb https://www.riscobiologico.org/psbio/psbio_201505.pdf](https://www.riscobiologico.org/psbio/psbio_201505.pdf)\n-\n31Santos SS, Costa NA, Mascarenhas MDM. Caracteriza\u00e7\u00e3o das exposi\u00e7\u00f5es ocupacionais a material biol\u00f3gico entre trabalhadores de hospitais no Munic\u00edpio de Teresina, Estado do Piau\u00ed, Brasil, 2007 a 2011. Epidemiol Serv Sa\u00fade. [Internet]. 2013 Jan-Mar [Acesso 12 dez 2018];22(1):165-70. Dispon\u00edvel em: http://scielo.iec.gov.br/pdf/ess/v22n1/v22n1a17.pdf\n[\u00bb http://scielo.iec.gov.br/pdf/ess/v22n1/v22n1a17.pdf](http://scielo.iec.gov.br/pdf/ess/v22n1/v22n1a17.pdf)\n-\n32Minist\u00e9rio da Sa\u00fade (BR). Secretaria de Vigil\u00e2ncia em Sa\u00fade. Departamento de Vigil\u00e2ncia das Doen\u00e7as Transmiss\u00edveis. Manual dos Centros de Refer\u00eancia para imunobiol\u00f3gicos especiais. [Internet]. 2014. [Acesso 12 dez 2018]. Dispon\u00edvel em http://portalarquivos.saude.gov.br/images/pdf/2014/dezembro/09/manual-cries-9dez14-web.pdf\n[\u00bb http://portalarquivos.saude.gov.br/images/pdf/2014/dezembro/09/manual-cries-9dez14-web.pdf](http://portalarquivos.saude.gov.br/images/pdf/2014/dezembro/09/manual-cries-9dez14-web.pdf)\n-\n33Petrou S, Gray A. Economic evaluation using decision analytical modelling: design, conduct, analysis, and reporting. BMJ. 2011;342:d1766. doi: https://doi.org/10.1136/bmj.d1766\n[\u00bb https://doi.org/10.1136/bmj.d1766](https://doi.org/10.1136/bmj.d1766)\n-\n34So\u00e1rez PC, Soares MO, Novaes HMD. Decision modeling for economic evaluation of health technologies. Ci\u00eanc Sa\u00fade Coletiva. [Internet]. 2014 [cited Jun 2, 2017];19 (10):4209-22. Available from: http://www.scielo.br/pdf/csc/v19n10/1413-8123-csc-19-10-4209.pdf\n[\u00bb http://www.scielo.br/pdf/csc/v19n10/1413-8123-csc-19-10-4209.pdf](http://www.scielo.br/pdf/csc/v19n10/1413-8123-csc-19-10-4209.pdf)\n-\n35Cordeiro TMSC, Carneiro JN Neto, Cardoso MCB, Mattos AIS, Santos KOB, Ara\u00fajo TM. Occupational accidents with exposure to biological material: description of cases in Bahia. J Epidemiol Infect Control. [Internet]. 2016 [cited Dec 12, 2018];6(2):1-7. doi: http://dx.doi.org/10.17058/reci.v6i2.6218\n[\u00bb http://dx.doi.org/10.17058/reci.v6i2.6218](http://dx.doi.org/10.17058/reci.v6i2.6218)\n-\n36Barros DX, Tipple AFV, Lima LKOL, Souza ACS, Neves ZCP, Salgado TA. Analysis of 10 years of accidents with biological material among the nursing staff. Rev Eletr Enferm. 2016;18:e1157. doi: http://dx.doi.org/10.5216/ree.v18.35493\n[\u00bb http://dx.doi.org/10.5216/ree.v18.35493](http://dx.doi.org/10.5216/ree.v18.35493)\n-\n37Samargandy SA, Bukhari LM, Samargandy SA, Bahlas RS, Aldigs EK, Alawi MA, et al. Epidemiology and clinical consequences of occupational exposure to blood and other body fluids in a university hospital in Saudi Arabia. Saudi Med J. [Internet]. 2016 [cited Nov 02, 2018];37(7):783-90. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5018644/pdf/SaudiMedJ-37-783.pdf\n[\u00bb https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5018644/pdf/SaudiMedJ-37-783.pdf](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5018644/pdf/SaudiMedJ-37-783.pdf)\n-\n38Kocur E, \u015aliwa-Rak BO, Grosicki S. Analysis of occupational exposures to blood registered in the General Hospital in Zabrze in the years 2006-2015. Przegl Epidemiol. [Internet]. 2016 [cited Fev 12, 2018];70(4):603-15. Available from: http://www.przeglepidemiol.pzh.gov.pl/pobierz-artykul?id=2120\n[\u00bb http://www.przeglepidemiol.pzh.gov.pl/pobierz-artykul?id=2120](http://www.przeglepidemiol.pzh.gov.pl/pobierz-artykul?id=2120)\n-\n39Silva AR, Ferreira OC Jr, S\u00e1 RSA, Correia AL Jr, Silva SGC, Carvalho MAL Netto, et al. HBV and HCV serological markers in health professionals and users of the Brazilian Unified Health System network in the city of Resende, Rio de Janeiro, Brazil. J Bras Patol Med Lab. [Internet]. 2017 [cited Jan 22, 2018];53(2): 92-9. Available from: http://www.scielo.br/pdf/jbpml/v53n2/1676-2444-jbpml-53-02-0092.pdf\n[\u00bb http://www.scielo.br/pdf/jbpml/v53n2/1676-2444-jbpml-53-02-0092.pdf](http://www.scielo.br/pdf/jbpml/v53n2/1676-2444-jbpml-53-02-0092.pdf)\n-\n40Almeida MCM, Canini SRMS, Reis RK, Toffano SEM, Pereira FMV, Gir E. Clinical treatment adherence of health care workers and students exposed to potentially infectious biological material. Rev Esc Enferm USP. [Internet]. 2015 [cited Jun 22, 2018];49(2):259-64. Available from: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0080-62342015000200259&lng=en&nrm=iso&tlng=en\n[\u00bb http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0080-62342015000200259&lng=en&nrm=iso&tlng=en](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0080-62342015000200259&lng=en&nrm=iso&tlng=en)\n-\n41Conselho Federal de Enfermagem (BR), FIOCRUZ. Perfil da enfermagem no Brasil. [Internet]. Goi\u00e1s: COFEN; 2015. [Acesso 22 jun 2018]. Dispon\u00edvel em: http://www.cofen.gov.br/perfilenfermagem/pdfs/relatoriofinal.pdf\n[\u00bb http://www.cofen.gov.br/perfilenfermagem/pdfs/relatoriofinal.pdf](http://www.cofen.gov.br/perfilenfermagem/pdfs/relatoriofinal.pdf)\n-\n42Santos EP Junior, Batista RRAM, Almeida ATF, Abreu RAA. Acidente de trabalho com material perfurocortante envolvendo profissionais e estudantes da \u00e1rea da sa\u00fade em hospital de refer\u00eancia. Rev Bras Med Trab. [Internet]. 2015 [Acesso 22 nov 2018];13(2):69-75. Dispon\u00edvel em: http://www.anamt.org.br/site/upload_arquivos/rbmt_volume_13_n%C2%BA_2_29320161552145795186.pdf\n[\u00bb http://www.anamt.org.br/site/upload_arquivos/rbmt_volume_13_n%C2%BA_2_29320161552145795186.pdf](http://www.anamt.org.br/site/upload_arquivos/rbmt_volume_13_n%C2%BA_2_29320161552145795186.pdf)\n-\n43Bush C, Schmid K, Rupp ME, Watanabe-Galloway S, Wolford B, Sandkovsky U. Bloodborne pathogen exposures: difference in reporting rates and individual predictors among health care personnel. Am J Infect Control. 2017;45(4):372-6. doi: https://doi.org/10.1016/j.ajic.2016.11.028\n[\u00bb https://doi.org/10.1016/j.ajic.2016.11.028](https://doi.org/10.1016/j.ajic.2016.11.028)\n-\n44Ream PS, Tipple AF, Salgado TA, Souza AC, Souza SM, Galdino-Junior H, et al. Hospital housekeepers: victims of ineffective hospital waste management. Arch Environ Occup Health. 2016;71(5):273-80. doi: https://doi.org/10.1080/19338244.2015.1089827\n[\u00bb https://doi.org/10.1080/19338244.2015.1089827](https://doi.org/10.1080/19338244.2015.1089827)\n-\n45Martins AMEBL, Costa FM, Ferreira RC, Santos PE Neto, Magalhaes TA, S\u00e1 MAB, et al. Factors associated with immunization against Hepatitis B among workers of the Family Health Strategy Program. Rev Bras Enferm. [Internet]. 2015 Jan/Fev [cited Set 25, 2018];68(1): 77-84. Available from: http://www.scielo.br/pdf/reben/v68n1/en_0034-7167-reben-68-01-0084.pdf\n[\u00bb http://www.scielo.br/pdf/reben/v68n1/en_0034-7167-reben-68-01-0084.pdf](http://www.scielo.br/pdf/reben/v68n1/en_0034-7167-reben-68-01-0084.pdf)\n-\n46Chang HH, Lee WK, Moon C, Choi WS, Yoon HJ, Kim J, et al. The acceptable duration between occupational exposure to hepatitis B virus and hepatitis B immunoglobulin injection: Results from a Korean nationwide, multicenter study. Am J Infect Control. 2016;44(2):189-93. doi: https://doi.org/10.1016/j.ajic.2015.08.024\n[\u00bb https://doi.org/10.1016/j.ajic.2015.08.024](https://doi.org/10.1016/j.ajic.2015.08.024)\n-\n47Pinelli C, Neri SN, Loffredo LCM. Dental students\u2019 reports of occupational exposures to potentially infectious biological material in a Brazilian School of Dentistry. Cad Sa\u00fade Colet. [Internet]. 2016 [cited Jan 21, 2018];24(2):162-9. Available from: http://www.scielo.br/pdf/cadsc/v24n2/1414-462X-cadsc-24-2-162.pdf\n[\u00bb http://www.scielo.br/pdf/cadsc/v24n2/1414-462X-cadsc-24-2-162.pdf](http://www.scielo.br/pdf/cadsc/v24n2/1414-462X-cadsc-24-2-162.pdf)\n-\n48Minist\u00e9rio da Sa\u00fade (BR). Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria. Resolu\u00e7\u00e3o RDC n\u00ba 11 de 13 de mar\u00e7o de 2014. Disp\u00f5e sobre os Requisitos de Boas Pr\u00e1ticas de Funcionamento para os Servi\u00e7os de Di\u00e1lise e d\u00e1 outras provid\u00eancias. [Internet]. [Acesso 20 jan 2018]. Dispon\u00edvelem:http://portal.anvisa.gov.br/documents/10181/2867923/(1)RDC_11_2014_COMP.pdf/5e552d92-f573-4c54-8cab-b06efa87036e\n[\u00bb http://portal.anvisa.gov.br/documents/10181/2867923/(1)RDC_11_2014_COMP.pdf/5e552d92-f573-4c54-8cab-b06efa87036e](http://portal.anvisa.gov.br/documents/10181/2867923/(1)RDC_11_2014_COMP.pdf/5e552d92-f573-4c54-8cab-b06efa87036e)\n-\n49Neves ZCP, Tipple AFV, Mendon\u00e7a KM, Souza ACS, Pereira MS. Brazilian legislation and recommendations related to occupational health and safety of health workers. Rev Eletr Enferm. [Internet]. 2017 [cited Jun 11, 2018];19:a01. Available from: https://revistas.ufg.br/fen/article/view/40427/22827\n[\u00bb https://revistas.ufg.br/fen/article/view/40427/22827](https://revistas.ufg.br/fen/article/view/40427/22827)\n-\n50Robotin M, Patton Y, Kansil M, Penman A, George J. Cost of treating chronic hepatitis B: comparison of current treatment guidelines. World J Gastroenterol. [Internet]. 2012 [cited Jan 15, 2018];18(42):6106-13. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496887/pdf/WJG-18-6106.pdf\n[\u00bb https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496887/pdf/WJG-18-6106.pdf](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496887/pdf/WJG-18-6106.pdf)\n-\n51Banerjee S, Gunda P, Drake RF, Hamed K. Telbivudine for the treatment of chronic hepatitis B in HBeAg-positive patients in China: a health economic analysis. [Internet]. Springerplus. 2016 [cited Nov 25, 2018];5(1):1719. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052247/pdf/40064_2016_Article_3404.pdf\n[\u00bb https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052247/pdf/40064_2016_Article_3404.pdf](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052247/pdf/40064_2016_Article_3404.pdf)\n-\n52Oliveira ML, Santos LMP, Silva EN. Bases metodol\u00f3gicas para estudos de custos da doen\u00e7a no Brasil. Rev Nutr. [Internet]. 2014 [Acesso 5 jun 2018];27:585-95. Dispon\u00edvel em: http://www.scielo.br/pdf/rn/v27n5/1415-5273-rn-27-05-00585.pdf\n[\u00bb http://www.scielo.br/pdf/rn/v27n5/1415-5273-rn-27-05-00585.pdf](http://www.scielo.br/pdf/rn/v27n5/1415-5273-rn-27-05-00585.pdf)\n-\n53Drummond MF, Sculpher MJ, Torrance GW, O\u2019Brien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press; 2005.\nEdited by\n-\nAssociate Editor: Maria L\u00facia do Carmo Cruz Robazzi\nPublication Dates\n-\nPublication in this collection\n19 June 2020\n-\nDate of issue\n2020\nHistory\n-\nReceived\n16 May 2019\n-\nAccepted\n03 Mar 2020", "language": null, "image": "https://www.scielo.br/media/images/rlae_glogo.gif", "pagetype": "article", "links": [null, "#", "/", "/journals/alpha?status=current", "/journals/thematic?status=current", "//search.scielo.org/?q=*&lang=pt&filter[in][]=scl", "http://analytics.scielo.org/?collection=scl", "/about/", "/about/", "//www.scielo.org", "//www.scielo.org", "//www.scielo.org/pt/periodicos/listar-por-ordem-alfabetica/", "//www.scielo.org/pt/periodicos/listar-por-assunto/", "//search.scielo.org/", "http://analytics.scielo.org", "//www.scielo.org/pt/sobre-o-scielo/acesso-via-oai-e-rss/", "//www.scielo.org/pt/sobre-o-scielo/", "//www.scielo.org/pt/sobre-o-scielo/contato/", "//blog.scielo.org", "", "/", "", "/j/rlae/", "http://mc04.manuscriptcentral.com/rlae-scielo", "/journal/rlae/about/#about", "/journal/rlae/about/#editors", "/journal/rlae/about/#instructions", "/journal/rlae/about/#contact", "/set_locale/es/", "/set_locale/en/", "", "/", "/set_locale/es/", "/set_locale/en/", "", "/j/rlae/", "http://mc04.manuscriptcentral.com/rlae-scielo", "/journal/rlae/about/#about", "/journal/rlae/about/#editors", "/journal/rlae/about/#instructions", "/journal/rlae/about/#contact", "/j/rlae/", "/j/rlae/i/2020.v28/", "/j/rlae/a/m3VTbQJzTKhv7ysBNvVJSTk/?lang=en&goto=previous", "#", "/j/rlae/a/m3VTbQJzTKhv7ysBNvVJSTk/?lang=en&goto=next", "/j/rlae/a/m3VTbQJzTKhv7ysBNvVJSTk/abstract/?lang=en", "/j/rlae/a/m3VTbQJzTKhv7ysBNvVJSTk/abstract/?lang=pt", "/j/rlae/a/m3VTbQJzTKhv7ysBNvVJSTk/abstract/?lang=es", "#", "/j/rlae/a/m3VTbQJzTKhv7ysBNvVJSTk/?lang=es", "/j/rlae/a/m3VTbQJzTKhv7ysBNvVJSTk/?lang=pt", "/j/rlae/a/m3VTbQJzTKhv7ysBNvVJSTk/?format=pdf&lang=es", "/j/rlae/a/m3VTbQJzTKhv7ysBNvVJSTk/?format=pdf&lang=en", "/j/rlae/a/m3VTbQJzTKhv7ysBNvVJSTk/?format=pdf&lang=pt", "javascript:;", "#", "#", "#", "#", "#", "#", "#", "#", "#", "/j/rlae/", "/j/rlae/i/2020.v28/", "javascript:;", "#", "#", "#", "#", "#", "#", "#", "#", "#", "/j/rlae/a/m3VTbQJzTKhv7ysBNvVJSTk/abstract/?lang=en", "/j/rlae/a/m3VTbQJzTKhv7ysBNvVJSTk/abstract/?lang=pt", "/j/rlae/a/m3VTbQJzTKhv7ysBNvVJSTk/abstract/?lang=es", "#", "/j/rlae/a/m3VTbQJzTKhv7ysBNvVJSTk/?lang=es", "/j/rlae/a/m3VTbQJzTKhv7ysBNvVJSTk/?lang=pt", "/j/rlae/a/m3VTbQJzTKhv7ysBNvVJSTk/?format=pdf&lang=es", "/j/rlae/a/m3VTbQJzTKhv7ysBNvVJSTk/?format=pdf&lang=en", "/j/rlae/a/m3VTbQJzTKhv7ysBNvVJSTk/?format=pdf&lang=pt", "https://doi.org/10.1590/1518-8345.3534.3278", null, "#", "", "", "https://apps.who.int/iris/bitstream/handle/10665/255016/9789241565455eng.pdf;jsessionid=0DA6245F73DE62CA74AFDA377EDEAAC9?sequence=1", "https://doi.org/10.1016/j.bjid.2012.12.005", "https://doi.org/10.1111/jvh.12482", "http://www.aids.gov.br/pt-br/pub/2019/boletim-epidemiologico-de-hepatites-virais-2019", "http://www.scielo.br/pdf/ean/v22n1/1414-8145-ean-2177-9465-EAN-2017-0140.pdf", "http://www.scielo.br/pdf/reben/v70n1/en_0034-7167-reben-70-01-0133.pdf", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753641/pdf/13104_2016_Article_1923.pdf", "https://doi.org/10.3390/ijerph14080843", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721280/pdf/1348-9585-59-581.pdf", "https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm", "http://bvsms.saude.gov.br/bvs/publicacoes/programa_nacional_imunizacoes_pni40.pdf", "https://doi.org/10.1016/S0749-3797(98)00003-8", "https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm", "https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm", "http://www.aids.gov.br/pt-br/pub/2015/protocolo-clinico-e-diretrizes-terapeuticas-para-profilaxia-pos-exposicao-pep-de-risco", "https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm", "https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm", "https://doi.org/10.1086/518729", "https://doi.org/10.1016/j.ajic.2012.01.030", "https://www.ncbi.nlm.nih.gov/pubmed/15789967", "https://doi.org/10.1185/030079907X219517", "https://doi.org/10.1017/ice.2016.48", "http://www.aids.gov.br/sites/default/files/pub/2016/59204/suplemento_consenso_adulto_01_24_01_2011_web_pdf_13627.pdf", "https://www20.anvisa.gov.br/segurancadopaciente/index.php/legislacao/item/portaria-n-485-de-11-de-novembro-de-2005", "https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm", "http://www.scielo.br/pdf/ean/v22n1/1414-8145-ean-2177-9465-EAN-2017-0140.pdf", "https://revistas.ufpr.br/cogitare/article/view/46508/pdf_en", "http://pgsskroton.com.br/seer/index.php/JHealthSci/article/view/5053/3683", "http://www.uvanet.br/essentia/index.php/revistaessentia/article/view/75/84", "https://doi.org/10.1016/j.ajic.2012.01.030", "http://scielo.iec.gov.br/pdf/ess/v25n2/2237-9622-ess-25-02-00437.pdf", "http://bvsms.saude.gov.br/bvs/publicacoes/diretrizes_metodologicas_diretriz_avaliacao_economica.pdf", "http://scielo.iec.gov.br/pdf/ess/v25n1/v25n1a23.pdf", "ftp://ftp.ibge.gov.br/Estimativas_de_Populacao/Estimativas_2017", "http://cnes.datasus.gov.br/pages/estabelecimentos/consulta.jsp", "https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm", "https://doi.org/10.1016/S0749-3797(98)00003-8", "https://revistas.ufpr.br/cogitare/article/view/46508/pdf_en", "http://www.jlponline.org/temp/JLabPhysicians9120-4059725_111637.pdf", "https://www.riscobiologico.org/psbio/psbio_201505.pdf", "http://scielo.iec.gov.br/pdf/ess/v22n1/v22n1a17.pdf", "https://revistas.ufpr.br/cogitare/article/view/46508/pdf_en", "https://www.riscobiologico.org/psbio/psbio_201505.pdf", "http://scielo.iec.gov.br/pdf/ess/v22n1/v22n1a17.pdf", "http://bvsms.saude.gov.br/bvs/publicacoes/programa_nacional_imunizacoes_pni40.pdf", "https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm", "https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm", "http://portalarquivos.saude.gov.br/images/pdf/2014/dezembro/09/manual-cries-9dez14-web.pdf", "https://doi.org/10.1136/bmj.d1766", "http://www.scielo.br/pdf/csc/v19n10/1413-8123-csc-19-10-4209.pdf", "http://scielo.iec.gov.br/pdf/ess/v25n2/2237-9622-ess-25-02-00437.pdf", "", "", null, "", null, "", null, "", "", "", "", "", null, "", "", null, null, "http://www.scielo.br/pdf/ean/v22n1/1414-8145-ean-2177-9465-EAN-2017-0140.pdf", "http://www.scielo.br/pdf/reben/v70n1/en_0034-7167-reben-70-01-0133.pdf", "https://revistas.ufpr.br/cogitare/article/view/46508/pdf_en", "http://dx.doi.org/10.17058/reci.v6i2.6218", "http://dx.doi.org/10.5216/ree.v18.35493", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721280/pdf/1348-9585-59-581.pdf", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5018644/pdf/SaudiMedJ-37-783.pdf", "http://www.przeglepidemiol.pzh.gov.pl/pobierz-artykul?id=2120", "http://www.scielo.br/pdf/jbpml/v53n2/1676-2444-jbpml-53-02-0092.pdf", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0080-62342015000200259&lng=en&nrm=iso&tlng=en", "http://www.cofen.gov.br/perfilenfermagem/pdfs/relatoriofinal.pdf", "http://www.cofen.gov.br/perfilenfermagem/pdfs/relatoriofinal.pdf", "https://revistas.ufpr.br/cogitare/article/view/46508/pdf_en", "http://www.jlponline.org/temp/JLabPhysicians9120-4059725_111637.pdf", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5018644/pdf/SaudiMedJ-37-783.pdf", "http://www.anamt.org.br/site/upload_arquivos/rbmt_volume_13_n%C2%BA_2_29320161552145795186.pdf", "https://doi.org/10.1016/j.ajic.2016.11.028", "http://dx.doi.org/10.5216/ree.v18.35493", "https://doi.org/10.1080/19338244.2015.1089827", "http://www.scielo.br/pdf/reben/v70n1/en_0034-7167-reben-70-01-0133.pdf", "https://revistas.ufpr.br/cogitare/article/view/46508/pdf_en", "http://www.anamt.org.br/site/upload_arquivos/rbmt_volume_13_n%C2%BA_2_29320161552145795186.pdf", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753641/pdf/13104_2016_Article_1923.pdf", "http://www.jlponline.org/temp/JLabPhysicians9120-4059725_111637.pdf", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5018644/pdf/SaudiMedJ-37-783.pdf", "https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm", "http://www.aids.gov.br/pt-br/pub/2015/protocolo-clinico-e-diretrizes-terapeuticas-para-profilaxia-pos-exposicao-pep-de-risco", "https://revistas.ufpr.br/cogitare/article/view/46508/pdf_en", "http://www.jlponline.org/temp/JLabPhysicians9120-4059725_111637.pdf", "http://dx.doi.org/10.17058/reci.v6i2.6218", "https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm", "http://www.aids.gov.br/pt-br/pub/2015/protocolo-clinico-e-diretrizes-terapeuticas-para-profilaxia-pos-exposicao-pep-de-risco", "http://www.scielo.br/pdf/reben/v68n1/en_0034-7167-reben-68-01-0084.pdf", "http://www.uvanet.br/essentia/index.php/revistaessentia/article/view/75/84", "http://dx.doi.org/10.5216/ree.v18.35493", "https://doi.org/10.1016/j.ajic.2015.08.024", "https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm", "http://www.aids.gov.br/pt-br/pub/2015/protocolo-clinico-e-diretrizes-terapeuticas-para-profilaxia-pos-exposicao-pep-de-risco", "https://revistas.ufpr.br/cogitare/article/view/46508/pdf_en", "http://pgsskroton.com.br/seer/index.php/JHealthSci/article/view/5053/3683", "http://www.uvanet.br/essentia/index.php/revistaessentia/article/view/75/84", "https://www.riscobiologico.org/psbio/psbio_201505.pdf", "http://scielo.iec.gov.br/pdf/ess/v22n1/v22n1a17.pdf", "http://www.scielo.br/pdf/cadsc/v24n2/1414-462X-cadsc-24-2-162.pdf", "https://revistas.ufpr.br/cogitare/article/view/46508/pdf_en", "https://www.riscobiologico.org/psbio/psbio_201505.pdf", "http://scielo.iec.gov.br/pdf/ess/v22n1/v22n1a17.pdf", "", "https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm", "https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm", "https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm", "http://portal.anvisa.gov.br/documents/10181/2867923/(1)RDC_11_2014_COMP.pdf/5e552d92-f573-4c54-8cab-b06efa87036e", "https://www20.anvisa.gov.br/segurancadopaciente/index.php/legislacao/item/portaria-n-485-de-11-de-novembro-de-2005", "", "https://revistas.ufg.br/fen/article/view/40427/22827", "", "", "", "", "", "https://www20.anvisa.gov.br/segurancadopaciente/index.php/legislacao/item/portaria-n-485-de-11-de-novembro-de-2005", "", "", "", "", "", "", "", "", "", "", "https://doi.org/10.1016/j.bjid.2012.12.005", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496887/pdf/WJG-18-6106.pdf", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052247/pdf/40064_2016_Article_3404.pdf", "http://www.scielo.br/pdf/rn/v27n5/1415-5273-rn-27-05-00585.pdf", "https://apps.who.int/iris/bitstream/handle/10665/255016/9789241565455eng.pdf;jsessionid=0DA6245F73DE62CA74AFDA377EDEAAC9?sequence=1", "https://doi.org/10.1016/j.bjid.2012.12.005", "https://doi.org/10.1111/jvh.12482", "http://www.aids.gov.br/pt-br/pub/2019/boletim-epidemiologico-de-hepatites-virais-2019", "http://www.scielo.br/pdf/ean/v22n1/1414-8145-ean-2177-9465-EAN-2017-0140.pdf", "http://www.scielo.br/pdf/reben/v70n1/en_0034-7167-reben-70-01-0133.pdf", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753641/pdf/13104_2016_Article_1923.pdf", "https://doi.org/10.3390/ijerph14080843", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721280/pdf/1348-9585-59-581.pdf", "https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm", "http://bvsms.saude.gov.br/bvs/publicacoes/programa_nacional_imunizacoes_pni40.pdf", "https://doi.org/10.1016/S0749-3797(98)00003-8", "http://www.aids.gov.br/pt-br/pub/2015/protocolo-clinico-e-diretrizes-terapeuticas-para-profilaxia-pos-exposicao-pep-de-risco", "https://doi.org/10.1086/518729", "https://doi.org/10.1016/j.ajic.2012.01.030", "https://www.ncbi.nlm.nih.gov/pubmed/15789967", "https://doi.org/10.1185/030079907X219517", "https://doi.org/10.1017/ice.2016.48", "http://www.aids.gov.br/sites/default/files/pub/2016/59204/suplemento_consenso_adulto_01_24_01_2011_web_pdf_13627.pdf", "https://www20.anvisa.gov.br/segurancadopaciente/index.php/legislacao/item/portaria-n-485-de-11-de-novembro-de-2005", "https://revistas.ufpr.br/cogitare/article/view/46508/pdf_en", "http://pgsskroton.com.br/seer/index.php/JHealthSci/article/view/5053/3683", "http://www.uvanet.br/essentia/index.php/revistaessentia/article/view/75/84", "http://scielo.iec.gov.br/pdf/ess/v25n2/2237-9622-ess-25-02-00437.pdf", "http://bvsms.saude.gov.br/bvs/publicacoes/diretrizes_metodologicas_diretriz_avaliacao_economica.pdf", "http://scielo.iec.gov.br/pdf/ess/v25n1/v25n1a23.pdf", "ftp://ftp.ibge.gov.br/Estimativas_de_Populacao/Estimativas_2017", "http://cnes.datasus.gov.br/pages/estabelecimentos/consulta.jsp", "http://www.jlponline.org/temp/JLabPhysicians9120-4059725_111637.pdf", "https://www.riscobiologico.org/psbio/psbio_201505.pdf", "http://scielo.iec.gov.br/pdf/ess/v22n1/v22n1a17.pdf", "http://portalarquivos.saude.gov.br/images/pdf/2014/dezembro/09/manual-cries-9dez14-web.pdf", "https://doi.org/10.1136/bmj.d1766", "http://www.scielo.br/pdf/csc/v19n10/1413-8123-csc-19-10-4209.pdf", "http://dx.doi.org/10.17058/reci.v6i2.6218", "http://dx.doi.org/10.5216/ree.v18.35493", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5018644/pdf/SaudiMedJ-37-783.pdf", "http://www.przeglepidemiol.pzh.gov.pl/pobierz-artykul?id=2120", "http://www.scielo.br/pdf/jbpml/v53n2/1676-2444-jbpml-53-02-0092.pdf", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0080-62342015000200259&lng=en&nrm=iso&tlng=en", "http://www.cofen.gov.br/perfilenfermagem/pdfs/relatoriofinal.pdf", "http://www.anamt.org.br/site/upload_arquivos/rbmt_volume_13_n%C2%BA_2_29320161552145795186.pdf", "https://doi.org/10.1016/j.ajic.2016.11.028", "https://doi.org/10.1080/19338244.2015.1089827", "http://www.scielo.br/pdf/reben/v68n1/en_0034-7167-reben-68-01-0084.pdf", "https://doi.org/10.1016/j.ajic.2015.08.024", "http://www.scielo.br/pdf/cadsc/v24n2/1414-462X-cadsc-24-2-162.pdf", "http://portal.anvisa.gov.br/documents/10181/2867923/(1)RDC_11_2014_COMP.pdf/5e552d92-f573-4c54-8cab-b06efa87036e", "https://revistas.ufg.br/fen/article/view/40427/22827", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496887/pdf/WJG-18-6106.pdf", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052247/pdf/40064_2016_Article_3404.pdf", "http://www.scielo.br/pdf/rn/v27n5/1415-5273-rn-27-05-00585.pdf", "https://creativecommons.org/licenses/by/4.0/", "https://creativecommons.org/licenses/by/4.0/", "", "http://orcid.org/0000-0002-1779-5909", "", "http://orcid.org/0000-0002-7652-4367", "", "http://orcid.org/0000-0001-5265-8195", "", "http://orcid.org/0000-0002-5570-8183", "", "http://orcid.org/0000-0001-7500-0230", "", "http://orcid.org/0000-0002-0812-2243", "mailto:anaclara.fen@gmail.com", "https://orcid.org/0000-0002-0812-2243", "", "", "", "", "", "#figures", "#tables", null, null, null, null, null, "https://minio.scielo.br/documentstore/1518-8345/m3VTbQJzTKhv7ysBNvVJSTk/ac3292316b1a4fb07de24dffcbeb88e11979f98d.jpg", "https://minio.scielo.br/documentstore/1518-8345/m3VTbQJzTKhv7ysBNvVJSTk/3fba3c2c314096300c64d68ee23849b98f7d9e93.jpg", "https://minio.scielo.br/documentstore/1518-8345/m3VTbQJzTKhv7ysBNvVJSTk/f70068d01d84339ee6b6dde5d87f8831227e7aff.jpg", "https://minio.scielo.br/documentstore/1518-8345/m3VTbQJzTKhv7ysBNvVJSTk/369cae01c66b93c607e4d66ffbe8715e24b6edda.jpg", null, "#top", "javascript:;", "javascript:;", "javascript:;", null, null, null, null, "javascript:;", "#top", "#", "#", "#", "#", "#", "#", "/journal/rlae/feed/", "/j/rlae/a/m3VTbQJzTKhv7ysBNvVJSTk/?lang=es&format=pdf", "/j/rlae/a/m3VTbQJzTKhv7ysBNvVJSTk/?lang=en&format=pdf", "/j/rlae/a/m3VTbQJzTKhv7ysBNvVJSTk/?lang=pt&format=pdf", "https://www.google.com/search?q=\"Post-vaccination anti-HBs testing among healthcare workers: More economical than post-exposure management for Hepatitis B\n\t\t\t\t\" \"Souza, Camila Lucas de\" \"Salgado, Tha\u00eds de Arvelos\" \"Sardeiro, Tatiana Luciano\" \"Galdino Junior, H\u00e9lio\" \"Itria, Alexander\" \"Tipple, Anaclara Ferreira Veiga\" \"2020\" \"Revista Latino-Americana de Enfermagem\"", "https://scholar.google.com/scholar?q=\"Post-vaccination anti-HBs testing among healthcare workers: More economical than post-exposure management for Hepatitis B\n\t\t\t\t\" \"Souza, Camila Lucas de\" \"Salgado, Tha\u00eds de Arvelos\" \"Sardeiro, Tatiana Luciano\" \"Galdino Junior, H\u00e9lio\" \"Itria, Alexander\" \"Tipple, Anaclara Ferreira Veiga\" \"2020\" \"Revista Latino-Americana de Enfermagem\"", "/j/rlae/a/m3VTbQJzTKhv7ysBNvVJSTk/?lang=en", "/j/rlae/a/m3VTbQJzTKhv7ysBNvVJSTk/?lang=es", "/j/rlae/a/m3VTbQJzTKhv7ysBNvVJSTk/?lang=pt", "", "", "/citation/export/m3VTbQJzTKhv7ysBNvVJSTk/?format=ris", "/citation/export/m3VTbQJzTKhv7ysBNvVJSTk/?format=bib", "http://www.fapesp.br/", "http://www.capes.gov.br/", "http://www.cnpq.br/", "http://bvsalud.org/", "http://regional.bvsalud.org/bvs/bireme/homepage.htm", "https://www.fapunifesp.edu.br/", "/about/", "http://analytics.scielo.org/w/accesses?document=S0104-11692020000100348&collection=scl", "https://badge.dimensions.ai/details/doi/10.1590/1518-8345.3534.3278", "https://www.altmetric.com/details.php?&doi=10.1590/1518-8345.3534.3278", "https://scite.ai/reports/10.1590/1518-8345.3534.3278", "https://plu.mx/scielo/a/?doi=10.1590/1518-8345.3534.3278", "https://plu.mx/scielo/a/?doi=10.1590/1518-8345.3534.3278"]}